Document:

Exhibit 4.29

 

CITIUS PHARMACEUTICALS,
INC.

 

and

 

         
      
      , as Trustee

 

INDENTURE

 

Dated as of      ,
20__      

 

TABLE OF CONTENTS

 

	 	 	 	 	PAGE	 
	ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE	 	 	1	 
	 	 	 
	1.1.	 	DEFINITIONS	 	 	1	 
	 	 	 
	1.2.	 	OTHER DEFINITIONS	 	 	4	 
	 	 	 
	1.3.	 	INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT	 	 	4	 
	 	 	 
	1.4.	 	RULES OF CONSTRUCTION	 	 	4	 
	 	 
	ARTICLE  2 THE SECURITIES	 	 	5	 
	 	 	 
	2.1.	 	ISSUABLE IN SERIES	 	 	5	 
	 	 	
	2.2.	 	ESTABLISHMENT OF TERMS OF SERIES OF SECURITIES	 	 	5	 
	 	 	 
	2.3.	 	EXECUTION AND AUTHENTICATION	 	 	7	 
	 	 	 
	2.4.	 	REGISTRAR AND PAYING AGENT	 	 	8	 
	 	 	 
	2.5.	 	PAYING AGENT TO HOLD ASSETS IN TRUST	 	 	8	 
	 	 	 
	2.6.	 	SECURITYHOLDER LISTS	 	 	9	 
	 	 	 
	2.7.	 	TRANSFER AND EXCHANGE	 	 	9	 
	 	 	 
	2.8.	 	REPLACEMENT SECURITIES	 	 	9	 
	 	 	 
	2.9.	 	OUTSTANDING SECURITIES	 	 	10	 
	 	 	 
	2.10.	 	WHEN TREASURY SECURITIES DISREGARDED; DETERMINATION OF HOLDERS’ ACTION	 	 	10	 
	 	 	 
	2.11.	 	TEMPORARY SECURITIES	 	 	10	 
	 	 	 
	2.12.	 	CANCELLATION	 	 	10	 
	 	 	 
	2.13.	 	PAYMENT OF INTEREST; DEFAULTED INTEREST; COMPUTATION OF INTEREST	 	 	11	 
	 	 	 
	2.14.	 	CUSIP NUMBER	 	 	11	 
	 	 	 
	2.15.	 	PROVISIONS FOR GLOBAL SECURITIES	 	 	11	 
	 	 	 
	2.16.	 	PERSONS DEEMED OWNERS	 	 	12	 

 

    i

    	 

    

 

	ARTICLE
    3 REDEMPTION	 	 	12	 
	 	 	 
	3.1.	 	NOTICES TO TRUSTEE	 	 	12	 
	 	 	 
	3.2.	 	SELECTION BY TRUSTEE OF SECURITIES TO BE REDEEMED	 	 	12	 
	 	 	 
	3.3.	 	NOTICE OF REDEMPTION	 	 	13	 
	 	 	 
	3.4.	 	EFFECT OF NOTICE OF REDEMPTION	 	 	14	 
	 	 	 
	3.5.	 	DEPOSIT OF REDEMPTION PRICE	 	 	14	 
	 	 	 
	3.6.	 	SECURITIES REDEEMED IN PART	 	 	14	 

 

	ARTICLE 4 COVENANTS	 	 	14	 
	 	 	 
	4.1.	 	PAYMENT OF SECURITIES	 	 	14	 
	 	 	 
	4.2.	 	SEC REPORTS	 	 	14	 
	 	 	 
	4.3.	 	WAIVER OF STAY, EXTENSION OR USURY LAWS	 	 	15	 
	 	 	 
	4.4.	 	COMPLIANCE CERTIFICATE	 	 	15	 
	 	 	 
	4.5.	 	CORPORATE EXISTENCE	 	 	15	 
	 	 
	ARTICLE 5 SUCCESSOR CORPORATION	 	 	16	 
	 	 	 
	5.1.	 	LIMITATION ON CONSOLIDATION, MERGER AND SALE OF ASSETS	 	 	16	 
	 	 	 
	5.2.	 	SUCCESSOR PERSON SUBSTITUTED	 	 	16	 
	 	 
	ARTICLE 6 DEFAULTS AND REMEDIES	 	 	16	 
	 	 	 
	6.1.	 	EVENTS OF DEFAULT	 	 	16	 
	 	 	 
	6.2.	 	ACCELERATION	 	 	17	 
	 	 	 
	6.3.	 	REMEDIES	 	 	17	 
	 	 	 
	6.4.	 	WAIVER OF PAST DEFAULTS AND EVENTS OF DEFAULT	 	 	18	 
	 	 	 
	6.5.	 	CONTROL BY MAJORITY	 	 	18	 
	 	 	 
	6.6.	 	LIMITATION ON SUITS	 	 	18	 
	 	 	 
	6.7.	 	RIGHTS OF HOLDERS TO RECEIVE PAYMENT	 	 	19	 
	 	 	 
	6.8.	 	COLLECTION SUIT BY TRUSTEE	 	 	19	 
	 	 	 
	6.9.	 	TRUSTEE MAY FILE PROOFS OF CLAIM	 	 	19	 
	 	 	 
	6.10.	 	PRIORITIES	 	 	19	 
	 	 	 
	6.11.	 	UNDERTAKING FOR COSTS	 	 	20	 
	 	 
	ARTICLE 7 TRUSTEE	 	 	20	 
	 	 	 
	7.1.	 	DUTIES OF TRUSTEE	 	 	20	 
	 	 	 
	7.2.	 	RIGHTS OF TRUSTEE	 	 	21	 

 

    ii

    	 

    

 

	7.3.	 	INDIVIDUAL RIGHTS OF TRUSTEE	 	 	22	 
	 	 	 
	7.4.	 	TRUSTEE’S DISCLAIMER	 	 	22	 
	 	 	 
	7.5.	 	NOTICE OF DEFAULT	 	 	22	 
	 	 	 
	7.6.	 	REPORTS BY TRUSTEE TO HOLDERS	 	 	22	 
	 	 	 
	7.7.	 	COMPENSATION AND INDEMNITY	 	 	22	 
	 	 	 
	7.8.	 	REPLACEMENT OF TRUSTEE	 	 	23	 

 

	7.9.	 	SUCCESSOR TRUSTEE BY CONSOLIDATION, MERGER OR CONVERSION	 	 	23	 
	 	 	 
	7.10.	 	ELIGIBILITY; DISQUALIFICATION	 	 	23	 
	 	 	 
	7.11.	 	PREFERENTIAL COLLECTION OF CLAIMS AGAINST COMPANY	 	 	24	 
	 	 	 
	7.12.	 	PAYING AGENTS	 	 	24	 
	 	 
	ARTICLE
    8 AMENDMENTS, SUPPLEMENTS AND WAIVERS	 	 	24	 
	 	 	 
	8.1.	 	WITHOUT CONSENT OF HOLDERS	 	 	24	 
	 	 	 
	8.2.	 	WITH CONSENT OF HOLDERS	 	 	25	 
	 	 	 
	8.3.	 	COMPLIANCE WITH TRUST INDENTURE ACT	 	 	26	 
	 	 	 
	8.4.	 	REVOCATION AND EFFECT OF CONSENTS	 	 	26	 
	 	 	 
	8.5.	 	NOTATION ON OR EXCHANGE OF SECURITIES	 	 	26	 
	 	 	 
	8.6.	 	TRUSTEE TO SIGN AMENDMENTS, ETC.	 	 	26	 
	 	 
	ARTICLE 9 DISCHARGE OF INDENTURE; DEFEASANCE	 	 	27	 
	 	 	 
	9.1.	 	DISCHARGE OF INDENTURE	 	 	27	 
	 	 	 
	9.2.	 	LEGAL DEFEASANCE	 	 	27	 
	 	 	 
	9.3.	 	COVENANT DEFEASANCE	 	 	27	 
	 	 	 
	9.4.	 	CONDITIONS TO LEGAL DEFEASANCE OR COVENANT DEFEASANCE	 	 	28	 
	 	 	 
	9.5.	 	DEPOSITED MONEY AND U.S. AND FOREIGN GOVERNMENT OBLIGATIONS TO BE HELD IN TRUST; OTHER MISCELLANEOUS PROVISIONS	 	 	29	 
	 	 	 
	9.6.	 	REINSTATEMENT	 	 	29	 
	 	 	 
	9.7.	 	MONEYS HELD BY PAYING AGENT	 	 	29	 
	 	 	 
	9.8.	 	MONEYS HELD BY TRUSTEE	 	 	30	 
	 	 
	ARTICLE 10 MISCELLANEOUS	 	 	30	 
	 	 	 
	10.1.	 	TRUST INDENTURE ACT CONTROLS	 	 	30	 
	 	 	 
	10.2.	 	NOTICES	 	 	30	 
	 	 	 
	10.3.	 	COMMUNICATIONS BY HOLDERS WITH OTHER HOLDERS	 	 	31	 

 

    iii

    	 

    

 

	10.4.	 	CERTIFICATE AND OPINION AS TO CONDITIONS PRECEDENT	 	 	31	 
	 	 	 
	10.5.	 	STATEMENT REQUIRED IN CERTIFICATE AND OPINION	 	 	31	 
	 	 	 
	10.6.	 	RULES BY TRUSTEE AND AGENTS	 	 	32	 
	 	 	 
	10.7.	 	BUSINESS DAYS; LEGAL HOLIDAYS; PLACE OF PAYMENT	 	 	32	 
	 	 	 
	10.8.	 	GOVERNING LAW	 	 	32	 
	 	 	 	 	 	 	 
	10.9.	 	NO ADVERSE INTERPRETATION OF OTHER AGREEMENTS	 	 	32	 
	 	 	 
	10.10.	 	NO RECOURSE AGAINST OTHERS	 	 	32	 
	 	 	 
	10.11.	 	SUCCESSORS	 	 	32	 
	 	 	 
	10.12.	 	MULTIPLE COUNTERPARTS	 	 	32	 
	 	 	 
	10.13.	 	TABLE OF CONTENTS, HEADINGS, ETC.	 	 	32	 
	 	 	 
	10.14.	 	SEVERABILITY	 	 	33	 
	 	 	 
	10.15.	 	SECURITIES IN A FOREIGN CURRENCY OR IN EUROS	 	 	33	 
	 	 	 
	10.16.	 	JUDGMENT CURRENCY	 	 	33	 

 

    iv

    	 

    

 

INDENTURE, dated as of
        , 20__, by and
between Citius Pharmaceuticals, Inc., a Nevada corporation, as Issuer (the “Company”) and             ,
a              organized
under the laws of           ,
as Trustee (the “Trustee”).

 

RECITALS OF THE COMPANY

 

The Company has duly
authorized the execution and delivery of this Indenture to provide for the issuance from time to time of its debentures, notes or other
evidences of indebtedness to be issued in one or more series (the “Securities”), as herein provided, up to such principal
amount as may from time to time be authorized in or pursuant to one or more resolutions of the Board of Directors or by supplemental indenture.

 

All things necessary
to make this Indenture a valid agreement of the Company in accordance with its terms have been done, and the execution and delivery thereof
have been in all respects duly authorized by the parties hereto.

 

NOW, THEREFORE, THIS
INDENTURE WITNESSETH:

 

For and in consideration
of the premises and the purchase of the Securities by the Holders thereof, it is mutually agreed, for the equal and proportionate benefit
of all Holders of the Securities of a Series thereof, as follows:

 

ARTICLE 1

 

DEFINITIONS AND INCORPORATION
BY REFERENCE

 

	1.1.	DEFINITIONS.

 

“Affiliate”
of any specified Person means any other Person which, directly or indirectly through one or more intermediaries, controls, or is controlled
by or is under common control with, such specified Person. For the purposes of this definition, “control” (including, with
correlative meanings, the terms “controlling,” “controlled by” and “under common control with”), as
used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management
or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise.

 

“Agent” means
any Registrar, Paying Agent, co-registrar or agent for service of notices and demands.

 

“Board of Directors”
means the Board of Directors of the Company or any committee duly authorized to act therefor.

 

“Board Resolution”
means a copy of a resolution certified pursuant to an Officers’ Certificate to have been duly adopted by the Board of Directors
of the Company and to be in full force and effect on the date of such certification which has been delivered to the Trustee.

 

“Capital Stock”
means, with respect to any Person, any and all shares or other equivalents (however designated) of capital stock, partnership interests
or any other participation, right or other interest in the nature of an equity interest in such Person or any option, warrant or other
security convertible into any of the foregoing.

 

“Company”
means the party named as such in the first paragraph of this Indenture until a successor replaces such party pursuant to Article 5 of
this Indenture, and thereafter means the successor and any other primary obligor on the Securities.

 

“Company Order”
means a written order signed in the name of the Company by two Officers, one of whom must be its Chief Executive Officer or its Chief
Financial Officer.

 

    1

    	 

    

 

“Company Request”
means any written request signed in the name of the Company by its Chief Executive Officer, its President, any Vice President, its Chief
Financial Officer or its Treasurer and attested to by its Secretary or any Assistant Secretary.

 

“Corporate Trust
Office” means the office of the Trustee at which at any particular time its corporate trust business shall be principally administered.

 

“Default”
means any event that is, or that with the passing of time or giving of notice or both would be, an Event of Default.

 

“Depository”
means, with respect to the Securities of any Series issuable or issued in whole or in part in the form of one or more Global Securities,
the Person designated as Depository for such Series by the Company, which Depository shall be a clearing agency registered under the Exchange
Act, until a successor Depository shall have become such pursuant to the applicable provisions of this Indenture, and thereafter “Depository”
shall mean each Person who is then a Depository hereunder, and if at any time there is more than one such Person, such Persons.

 

“Dollars”
means the currency of the United States of America.

 

“Euro” means
the single currency of participating member states of the economic and monetary union as contemplated in the Treaty on European Union.

 

“Exchange Act”
means the Securities Exchange Act of 1934, as amended.

 

“Foreign Currency”
means any currency or currency unit issued by a government other than the government of the United States of America.

 

“Foreign Government
Obligations” means, with respect to Securities that are denominated in a Foreign Currency, (i) direct obligations of the government
that issued or caused to be issued such currency for the payment of which obligations its full faith and credit is pledged or (ii) obligations
of a Person controlled or supervised by, or acting as an agency or instrumentality of, such government, the timely payment of which is
unconditionally guaranteed as a full faith and credit obligation by such government, which, in either case under clauses (i) and
(ii), are not callable or redeemable at the option of the issuer thereof.

 

“GAAP” means
generally accepted accounting principles consistently applied as in effect in the United States of America from time to time.

 

“Global Security”
or “Global Securities” means a Security or Securities, as the case may be, in the form established pursuant to Section 2.2,
evidencing all or part of a Series of Securities issued to the Depository for such Series or its nominee, and registered in the name of
such Depository or nominee, and bearing the legend set forth in Section 2.15(c) (or such other legend(s) as may be applied to such
Securities in accordance with Section 2.2(24)).

 

“Holder”
or “Securityholder” means the Person in whose name a Security is registered on the Registrar’s books.

 

“Indebtedness”
means (without duplication), with respect to any Person, any indebtedness at any time outstanding, secured or unsecured, contingent or
otherwise, which is for borrowed money (whether or not the recourse of the lender is to the whole of the assets of such Person or only
to a portion thereof), or evidenced by bonds, notes, debentures or similar instruments, or representing the balance deferred and unpaid
of the purchase price of any property (excluding any balances that constitute accounts payable or trade payables, and other accrued liabilities
arising in the ordinary course of business), if and to the extent any of the foregoing indebtedness would appear as a liability upon a
balance sheet of such Person prepared in accordance with GAAP.

 

“Indenture”
means this Indenture as amended, restated or supplemented from time to time.

 

    2

    	 

    

 

“Interest Payment
Date,” when used with respect to any Security, means the Stated Maturity of an installment of interest on such Security.

 

“Lien” means,
with respect to any property or assets of any Person, any mortgage or deed of trust, pledge, hypothecation, assignment, deposit arrangement,
security interest, lien, charge, easement, encumbrance, preference, priority or other security agreement or preferential arrangement of
any kind or nature whatsoever on or with respect to such property or assets (including, without limitation, any capitalized lease obligation,
conditional sales or other title retention agreement having substantially the same economic effect as any of the foregoing).

 

“Maturity,”
when used with respect to any Security, means the date on which the principal of such Security, or an installment of principal, becomes
due and payable as therein or herein provided, whether at the Stated Maturity or by declaration of acceleration, call for redemption,
notice of option to elect payment or otherwise.

 

“Officer”
means the Chief Executive Officer, the President, any Vice President, the Chief Financial Officer, the Treasurer or the Secretary of the
Company, or any other officer designated by the Board of Directors, as the case may be.

 

“Officers’
Certificate” means, with respect to any Person, a certificate signed by the Chairman, Chief Executive Officer, President or any
Senior or Executive Vice President and the Chief Financial Officer or any Treasurer of such Person, that shall comply with applicable
provisions of this Indenture.

 

“Opinion of Counsel”
means a written opinion from legal counsel, which counsel is reasonably acceptable to the Trustee. The counsel may be an employee of or
counsel to the Company.

 

“Person”
means any individual, corporation, limited liability company, partnership, joint venture, association, joint-stock company, trust, unincorporated
organization or government (including any agency or political subdivision thereof).

 

“Redemption Date,”
when used with respect to any Security to be redeemed, means the date fixed for such redemption pursuant to this Indenture.

 

“Responsible Officer,”
when used with respect to the Trustee, means any officer within the corporate trust department or division of the Trustee (or any successor
group of the Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of the above
designated officers, and also means, with respect to a particular corporate trust matter, any other officer to whom such matter is referred
because of his knowledge of and familiarity with the particular subject.

 

“SEC” means
the United States Securities and Exchange Commission as constituted from time to time, or any successor performing substantially the same
functions.

 

“Securities”
means the securities that are issued under this Indenture, as amended or supplemented from time to time pursuant to this Indenture.

 

“Securities Act”
means the Securities Act of 1933, as amended.

 

“Series”
or “Series of Securities” means each series of debentures, notes or other debt instruments of the Company created pursuant
to Sections 2.1 and 2.2.

 

“Significant Subsidiary”
means (i) any direct or indirect Subsidiary of the Company that would be a “significant subsidiary” as defined in Article
1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such regulation is in effect on the date hereof, or (ii) any
group of direct or indirect Subsidiaries of the Company that, taken together as a group, would be a “significant subsidiary”
as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such regulation is in effect on the
date hereof.

 

    3

    	 

    

 

“Stated Maturity,”
when used with respect to any Security or any installment of principal thereof or interest thereon, means the date specified in such Security
as the fixed date on which the principal of such Security, or such installment of principal or interest, is due and payable, and when
used with respect to any other Indebtedness, means the date specified in the instrument governing such Indebtedness as the fixed date
on which the principal of such Indebtedness, or any installment of interest thereon, is due and payable.

 

“Subsidiary”
of any specified Person means any corporation, limited liability company, partnership, joint venture, association or other business entity,
whether now existing or hereafter organized or acquired, (i) in the case of a corporation, of which more than 50% of the total voting
power of the Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors thereof
is held, directly or indirectly, by such Person or any of its Subsidiaries; or (ii) in the case of a partnership, joint venture,
association or other business entity, with respect to which such Person or any of its Subsidiaries has the power to direct or cause the
direction of the management and policies of such entity by contract or otherwise, or if in accordance with GAAP such entity is consolidated
with such Person for financial statement purposes.

 

“TIA” means
the Trust Indenture Act of 1939 (15 U.S. Code Section 77aaa-77bbbb) as in effect on the date of this Indenture (except as provided in
Section 8.3).

 

“Trustee”
means the party named as such in this Indenture until a successor replaces it pursuant to this Indenture, and thereafter means the successor,
and if at any time there is more than one such Person, “Trustee” as used with respect to the Securities of any Series shall
mean the Trustee with respect to Securities of that Series.

 

“U.S. Government
Obligations” means direct non-callable obligations of, or non-callable obligations guaranteed by, the United States of America for
the payment of which obligation or guarantee the full faith and credit of the United States of America is pledged.

 

	1.2.	RESERVED.

 

	1.3.	INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT.

 

Whenever this Indenture
refers to a provision of the TIA, the portion of such provision required to be incorporated herein in order for this Indenture to be qualified
under the TIA is incorporated by reference in and made a part of this Indenture. The following TIA terms used in this Indenture have the
following meanings:

 

“Commission”
means the SEC.

 

“indenture securities”
means the Securities.

 

“indenture securityholder”
means a Holder or Securityholder.

 

“indenture to be
qualified” means this Indenture.

 

“indenture trustee”
or “institutional trustee” means the Trustee.

 

“obligor on the
indenture securities” means the Company.

 

All other terms used
in this Indenture that are defined by the TIA, defined in the TIA by reference to another statute or defined by SEC rule have the meanings
therein assigned to them.

 

	1.4.	RULES OF CONSTRUCTION.

 

Unless the context otherwise
requires:

 

(1) a term has the meaning
assigned to it herein, whether defined expressly or by reference;

 

(2) an accounting term
not otherwise defined has the meaning assigned to it in accordance with GAAP;

 

    4

    	 

    

 

(3) “or”
is not exclusive;

 

(4) words in the singular
include the plural, and in the plural include the singular;

 

(5) words used herein
implying any gender shall apply to each gender; and

 

(6) the words “herein”,
“hereof” and “hereunder” and other words of similar import refer to this Indenture as a whole and not to any particular
Article, Section or other subdivision.

 

ARTICLE 2

 

THE SECURITIES

 

	2.1.	ISSUABLE IN SERIES.

 

The aggregate principal
amount of Securities that may be authenticated and delivered under this Indenture is $[      ].
The Securities may be issued in one or more Series. All Securities of a Series shall be identical except as may be set forth in a Board
Resolution, a supplemental indenture or an Officers’ Certificate detailing the adoption of the terms thereof pursuant to the authority
granted under a Board Resolution. In the case of Securities of a Series to be issued from time to time, the Board Resolution, Officers’
Certificate or supplemental indenture may provide for the method by which specified terms (such as interest rate, Stated Maturity, record
date or date from which interest shall accrue) are to be determined. Securities may differ between Series in respect of any matters, PROVIDED,
that all Series of Securities shall be equally and ratably entitled to the benefits of the Indenture.

 

	2.2.	ESTABLISHMENT OF TERMS OF SERIES OF SECURITIES.

 

At or prior to the issuance
of any Securities within a Series, the following shall be established (as to the Series generally, in the case of Subsection 2.2(1) and
either as to such Securities within the Series or as to the Series generally in the case of Subsections 2.2(2) through 2.2(24)) by a Board
Resolution, a supplemental indenture or an Officers’ Certificate, in each case, pursuant to authority granted under a Board Resolution:

 

(1) the title of the
Series (which shall distinguish the Securities of that particular Series from the Securities of any other Series);

 

(2) any limit upon the
aggregate principal amount of the Securities of the Series which may be authenticated and delivered under this Indenture (except for Securities
authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of the Series pursuant
to Section 2.7, 2.8, 2.11, 3.6 or 8.5);

 

(3) the price or prices
(expressed as a percentage of the principal amount thereof) at which the Securities of the Series will be issued;

 

(4) the date or dates
on which the principal of the Securities of the Series is payable;

 

(5) the rate or rates
(which may be fixed or variable) per annum or, if applicable, the method used to determine such rate or rates (including, but not limited
to, any commodity, commodity index, stock exchange index or financial index) at which the Securities of the Series shall bear interest,
if any, the date or dates from which such interest, if any, shall accrue, the date or dates on which such interest, if any, shall commence
and be payable and any regular record date for the interest payable on any Interest Payment Date;

 

(6) the place or places
where the principal of, and interest and premium, if any, on, the Securities of the Series shall be payable, or the method of such payment,
if by wire transfer, mail or other means;

 

    5

    	 

    

 

(7) if applicable, the
period or periods within which, the price or prices at which and the terms and conditions upon which the Securities of the Series may
be redeemed, in whole or in part, at the option of the Company;

 

(8) the obligation, if
any, of the Company to redeem or purchase the Securities of the Series pursuant to any sinking fund or analogous provisions or at the
option of a Holder thereof, and the period or periods within which, the price or prices at which and the terms and conditions upon which
Securities of the Series shall be redeemed or purchased, in whole or in part, pursuant to such obligation;

 

(9) the dates, if any,
on which and the price or prices at which the Securities of the Series will be repurchased by the Company at the option of the Holders
thereof, and other detailed terms and provisions of such repurchase obligations;

 

(10) if other than denominations
of $1,000 and any integral multiple thereof, the denominations in which the Securities of the Series shall be issuable;

 

(11) the forms of the
Securities of the Series in bearer (if to be issued outside of the United States of America) or fully registered form (and, if in fully
registered form, whether the Securities will be issuable as Global Securities);

 

(12) if other than the
principal amount thereof, the portion of the principal amount of the Securities of the Series that shall be payable upon declaration of
acceleration of the Maturity thereof pursuant to Section 6.2;

 

(13) the currency of
denomination of the Securities of the Series, which may be Dollars or any Foreign Currency, including, but not limited to, the Euro, and,
if such currency of denomination is a composite currency other than the Euro, the agency or organization, if any, responsible for overseeing
such composite currency;

 

(14) the designation
of the currency, currencies or currency units in which payment of the principal of, and interest and premium, if any, on, the Securities
of the Series will be made;

 

(15) if payments of principal
of, or interest or premium, if any, on, the Securities of the Series are to be made in one or more currencies or currency units other
than that or those in which such Securities are denominated, the manner in which the exchange rate with respect to such payments will
be determined;

 

(16) the manner in which
the amounts of payment of principal of, or interest and premium, if any, on, the Securities of the Series will be determined, if such
amounts may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index,
stock exchange index or financial index;

 

(17) the provisions,
if any, relating to any collateral provided for the Securities of the Series;

 

(18) any addition to
or change in the covenants set forth in Articles 4 or 5 that applies to Securities of the Series;

 

(19) any addition to
or change in the Events of Default which applies to any Securities of the Series, and any change in the right of the Trustee or the requisite
Holders of such Securities to declare the principal amount thereof due and payable pursuant to Section 6.2;

 

(20) the terms and conditions,
if any, for conversion of the Securities into or exchange of the Securities for shares of common stock or preferred stock of the Company
that apply to Securities of the Series;

 

(21) any depositories,
interest rate calculation agents, exchange rate calculation agents or other agents with respect to Securities of such Series if other
than those appointed herein;

 

    6

    	 

    

 

(22) the terms and conditions,
if any, upon which the Securities shall be subordinated in right of payment to other Indebtedness of the Company;

 

(23) if applicable, that
the Securities of the Series, in whole or any specified part, shall be defeasible pursuant to Article 9; and

 

(24) any other terms
of the Securities of the Series (which terms shall not be inconsistent with the provisions of this Indenture, except as permitted by Section 8.1,
but which may modify or delete any provision of this Indenture insofar as it applies to such Series).

 

All Securities of any
one Series need not be issued at the same time, and may be issued from time to time, consistent with the terms of this Indenture, if so
provided by or pursuant to the Board Resolution, supplemental indenture or Officers’ Certificate referred to above, however, the
authorized principal amount of any Series may not be increased to provide for issuances of additional Securities of such Series, unless
otherwise provided in such Board Resolution, supplemental indenture or Officers’ Certificate.

 

	2.3.	EXECUTION AND AUTHENTICATION.

 

The Securities shall
be executed on behalf of the Company by two Officers of the Company or an Officer and an Assistant Secretary of the Company. Each such
signature may be either manual or facsimile. The Company’s seal, if any, may be impressed, affixed, imprinted or reproduced on the
Securities and may be in facsimile form.

 

If an Officer whose signature
is on a Security no longer holds that office at the time the Security is authenticated, the Security shall nevertheless be valid.

 

A Security shall not
be valid until authenticated by the manual signature of the Trustee or an authenticating agent. The signature shall be conclusive evidence
that the Security has been authenticated under this Indenture. The Trustee shall at any time, and from time to time, authenticate Securities
for original issue in the principal amount provided in the Board Resolution, supplemental indenture hereto or Officers’ Certificate,
upon receipt by the Trustee of a Company Order. Such Company Order may authorize authentication and delivery pursuant to oral or electronic
instructions from the Company or its duly authorized agent or agents, which oral instructions shall be promptly confirmed in writing.
Each Security shall be dated the date of its authentication.

 

The aggregate principal
amount of Securities of any Series outstanding at any time may not exceed any limit upon the maximum principal amount for such Series
set forth in the Board Resolution, supplemental indenture hereto or Officers’ Certificate delivered pursuant to Section 2.2, except
as provided in Section 2.8.

 

Prior to the issuance
of Securities of any Series, the Trustee shall have received and (subject to Section 7.1) shall be fully protected in relying on: (a)
the Board Resolution, supplemental indenture hereto or Officers’ Certificate establishing the form of the Securities of that Series
or of Securities within that Series and the terms of the Securities of that Series or of Securities within that Series, (b) an Officers’
Certificate complying with Section 10.4, and (c) an Opinion of Counsel complying with Section 10.4.

 

The Trustee shall have
the right to decline to authenticate and deliver any Securities of any Series: (a) if the Trustee, being advised in writing by outside
counsel, determines that such action may not lawfully be taken; or (b) if the Trustee in good faith by its board of directors or
trustees, executive committee or a trust committee of directors and/or vice-presidents shall reasonably determine that such action would
expose the Trustee to personal liability, or cause it to have a conflict of interest with respect to Holders of any then outstanding Series
of Securities.

 

The Trustee may appoint
an authenticating agent acceptable to the Company to authenticate Securities. An authenticating agent may authenticate Securities whenever
the Trustee may do so. Any appointment shall be evidenced by an instrument signed by an authorized officer of the Trustee, a copy of which
shall be furnished to the Company. Each reference in this Indenture to authentication by the Trustee includes authentication by such agent.
An authenticating agent has the same rights as an Agent to deal with the Company or an Affiliate of the Company.

 

    7

    	 

    

 

	2.4.	REGISTRAR AND PAYING AGENT.

 

The Company shall maintain
in each Place of Payment for any Series of Securities (i) an office or agency where such Securities may be presented for registration
of transfer or for exchange (“Registrar”), (ii) an office or agency where such Securities may be presented for payment
(“Paying Agent”) (PROVIDED that the Company shall at all times maintain a Paying Agent in the Borough of Manhattan, City of
New York, State of New York (the “New York Paying Agent”), and PROVIDED, FURTHER, that at the option of the Company payment
of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the register for
the Securities maintained by the Registrar), and (iii) an office or agency where notices and demands to or upon the Company in respect
of the Securities and this Indenture may be served (“Service Agent”). The Registrar shall keep a register of the Securities
and of their transfer and exchange. The Company may have one or more co-registrars and one or more additional paying agents. The Company
shall give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. If at any time
the Company shall fail to maintain any such required office, or to furnish the Trustee with the address thereof, such presentations, surrenders,
notices and demands may be made or served at the address of the Trustee as set forth in Section 10.2. If the Company acts as Paying
Agent, it shall segregate the money held by it for the payment of principal of, and interest and premium, if any, on, the Securities and
hold it as a separate trust fund. The Company may change any Paying Agent, Registrar, co-registrar or any other Agent without notice to
any Securityholder.

 

The Company may also
from time to time designate one or more other offices or agencies where the Securities may be presented or surrendered for any or all
such purposes, and may from time to time rescind such designations; PROVIDED, HOWEVER, that no such designation or rescission shall in
any manner relieve the Company of its obligation to maintain an office or agency in each Place of Payment for Securities of any Series
for such purposes. The Company hereby initially designates the Corporate Trust Office of the Trustee as such office of the Company. The
Company shall give prompt written notice to the Trustee of such designation or rescission, and of any change in the location of any such
other office or agency.

 

The Company shall enter
into an appropriate agency agreement with any Registrar or Paying Agent not a party to this Indenture. The agreement shall implement the
provisions of this Indenture that relate to such Agent. The Company shall notify the Trustee of the name and address of any such Agent.
If the Company fails to maintain a Registrar or Paying Agent, or agent for service of notices and demands, or fails to give the foregoing
notice, the Trustee shall act as such. The Company hereby appoints the Trustee as the initial Registrar, Paying Agent and Service Agent
for each Series unless another Registrar, Paying Agent or Service Agent, as the case may be, is appointed prior to the time Securities
of that Series are first issued. The Company designates                                         ,
as the New York Paying Agent, with offices at                                        .

 

	2.5.	PAYING AGENT TO HOLD ASSETS IN TRUST.

 

The Trustee as Paying
Agent shall, and the Company shall require each Paying Agent other than the Trustee to agree in writing that each Paying Agent shall,
hold in trust for the benefit of the Holders of any Series of Securities or the Trustee all assets held by the Paying Agent for the payment
of principal of, or interest or premium, if any, on, such Series of Securities (whether such assets have been distributed to it by the
Company or any other obligor on such Series of Securities), and the Company and the Paying Agent shall notify the Trustee in writing of
any Default by the Company (or any other obligor on such Series of Securities) in making any such payment. The Company at any time may
require a Paying Agent to distribute all assets held by it to the Trustee and account for any assets disbursed, and the Trustee may, at
any time during the continuance of any payment default with respect to any Series of Securities, upon written request to a Paying Agent,
require such Paying Agent to distribute all assets held by it to the Trustee and to account for any assets distributed. Upon distribution
to the Trustee of all assets that shall have been delivered by the Company to the Paying Agent, the Paying Agent shall have no further
liability for such assets.

 

    8

    	 

    

 

	2.6.	SECURITYHOLDER LISTS.

 

The Trustee shall preserve
in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of Securityholders of
each Series of Securities. If the Trustee is not the Registrar, the Company shall furnish to the Trustee as of each regular record date
for the payment of interest on the Securities of a Series and before each related Interest Payment Date, and at such other times as the
Trustee may request in writing, a list in such form and as of such date as the Trustee may reasonably require of the names and addresses
of Securityholders of each Series of Securities.

 

	2.7.	TRANSFER AND EXCHANGE.

 

When Securities of a
Series are presented to the Registrar with a request to register the transfer thereof, the Registrar shall register the transfer as requested
if the requirements of applicable law are met, and when such Securities of a Series are presented to the Registrar with a request to exchange
them for an equal principal amount of other authorized denominations of Securities of the same Series, the Registrar shall make the exchange
as requested. To permit transfers and exchanges, upon surrender of any Security for registration of transfer at the office or agency maintained
pursuant to Section 2.4, the Company shall execute and the Trustee shall authenticate Securities at the Registrar’s request.

 

If Securities are issued
as Global Securities, the provisions of Section 2.15 shall apply.

 

All Securities issued
upon any registration of transfer or exchange of Securities shall be the valid obligations of the Company, evidencing the same debt, and
entitled to the same benefits under this Indenture, as the Securities surrendered upon such registration of transfer or exchange.

 

Every Security presented
or surrendered for registration of transfer or for exchange shall (if so required by the Company or the Registrar or a co-registrar) be
duly endorsed, or be accompanied by a written instrument of transfer in form satisfactory to the Company and the Registrar or a co-registrar,
duly executed by the Holder thereof or his attorney duly authorized in writing.

 

Any exchange or transfer
shall be without charge, except that the Company may require payment by the Holder of a sum sufficient to cover any tax or other governmental
charge that may be imposed in relation to a transfer or exchange, but this provision shall not apply to any exchange pursuant to Section 2.11,
3.6 or 8.5. The Trustee shall not be required to register transfers of Securities of any Series, or to exchange Securities of any Series,
for a period of 15 days before the record date for selection for redemption of such Securities. The Trustee shall not be required to exchange
or register transfers of Securities of any Series called or being called for redemption in whole or in part, except the unredeemed portion
of such Security being redeemed in part.

 

	2.8.	REPLACEMENT SECURITIES.

 

If a mutilated Security
is surrendered to the Trustee, or if the Holder of a Security presents evidence to the satisfaction of the Company and the Trustee that
the Security has been lost, destroyed or wrongfully taken, the Company shall issue and the Trustee shall authenticate a replacement Security
of the same Series and of like tenor and principal amount and bearing a number not contemporaneously outstanding. An indemnity bond may
be required by the Company or the Trustee that is sufficient in the reasonable judgment of the Company or the Trustee, as the case may
be, to protect the Company, the Trustee or any Agent from any loss which any of them may suffer if a Security is replaced. The Company
may charge such Holder for the Company’s out-of-pocket expenses in replacing a Security, including the fees and expenses of the
Trustee. Every replacement Security shall constitute an original additional obligation of the Company, whether or not the destroyed, lost
or stolen Security shall be at any time enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and
proportionately with any and all other Securities of that Series duly issued hereunder.

 

    9

    	 

    

 

	2.9.	OUTSTANDING SECURITIES.

 

Securities outstanding
at any time are all Securities authenticated by the Trustee, except for those canceled by it, those delivered to it for cancellation and
those described in this Section 2.9 as not outstanding.

 

If a Security is replaced
pursuant to Section 2.8 (other than a mutilated Security surrendered for replacement), it ceases to be outstanding until the Company
and the Trustee receive proof satisfactory to each of them that the replaced Security is held by a bona fide purchaser. A mutilated Security
ceases to be outstanding upon surrender of such Security and replacement thereof pursuant to Section 2.8.

 

If a Paying Agent holds
on a Redemption Date or the Stated Maturity money sufficient to pay the principal of, premium, if any, and accrued interest on, Securities
payable on that date, and is not prohibited from paying such money to the Holders thereof pursuant to the terms of this Indenture (PROVIDED,
that if such Securities are to be redeemed, notice of such redemption has been duly given pursuant to this Indenture or provision therefor
satisfactory to the Trustee has been made), then on and after that date such Securities cease to be outstanding and interest on them ceases
to accrue.

 

A Security does not cease
to be outstanding solely because the Company or an Affiliate holds the Security.

 

	2.10.	WHEN TREASURY SECURITIES DISREGARDED; DETERMINATION OF HOLDERS’ ACTION.

 

In determining whether
the Holders of the required aggregate principal amount of the Securities of any Series have concurred in any direction, waiver or consent,
the Securities of any Series owned by the Company or any other obligor on such Securities, or by any Affiliate of any of them, shall be
disregarded, except that for the purposes of determining whether the Trustee shall be protected in relying on any such direction, waiver
or consent, only Securities of such Series which the Trustee actually knows are so owned shall be so disregarded. Securities of such Series
so owned which have been pledged in good faith shall not be disregarded if the pledgee establishes to the satisfaction of the Trustee
the pledgee’s right so to act with respect to the Securities of such Series and that the pledgee is not the Company or any other
obligor on the Securities of such Series, or an Affiliate of any of them.

 

	2.11.	TEMPORARY SECURITIES.

 

Until definitive Securities
are ready for delivery, the Company may prepare and execute, and the Trustee shall authenticate, temporary Securities. Temporary Securities
shall be substantially in the form, and shall carry all rights, of definitive Securities, but may have variations that the Company considers
appropriate for temporary Securities. Without unreasonable delay, the Company shall prepare and execute, and the Trustee shall authenticate,
definitive Securities in exchange for temporary Securities without charge to the Holder.

 

	2.12.	CANCELLATION.

 

All Securities surrendered
for payment, redemption or registration of transfer or exchange, or for credit against any sinking fund payment, shall, if surrendered
to any Person other than the Trustee, be delivered to the Trustee for cancellation. The Company may at any time deliver to the Trustee
for cancellation any Securities previously authenticated and delivered hereunder which the Company may have acquired in any manner whatsoever,
and may deliver to the Trustee (or to any other Person for delivery to the Trustee) for cancellation any Securities previously authenticated
hereunder which the Company has not issued and sold. The Registrar and the Paying Agent shall forward to the Trustee any Securities surrendered
to them for transfer, exchange or payment. The Trustee or, at the direction of the Trustee, the Registrar or the Paying Agent, and no
one else, shall cancel, and at the written request of the Company shall dispose of, all Securities surrendered for transfer, exchange,
payment or cancellation. If the Company shall acquire any of the Securities, such acquisition shall not operate as a redemption or satisfaction
of the Indebtedness represented by such Securities unless and until the same are surrendered to the Trustee for cancellation pursuant
to this Section 2.12. No Securities shall be authenticated in lieu of or in exchange for any Securities cancelled as provided in this
Section 2.12, except as expressly permitted by this Indenture.

 

    10

    	 

    

 

	2.13.	PAYMENT OF INTEREST; DEFAULTED INTEREST; COMPUTATION OF INTEREST.

 

Except as otherwise provided
as contemplated by Section 2.2 with respect to any Series of Securities, interest on any Security which is payable, and is punctually
paid or duly provided for, on any Interest Payment Date shall be paid to the Person in whose name that Security is registered at the close
of business on the regular record date for such interest, as provided in the Board Resolution, supplemental indenture hereto or Officers’
Certificate establishing the terms of such Series.

 

If the Company defaults
in a payment of interest on the Securities, it shall pay the defaulted amounts, plus any interest payable on defaulted amounts pursuant
to Section 4.1, to the Persons who are Securityholders on a subsequent special record date, which date shall be the 15th day next preceding
the date fixed by the Company for the payment of defaulted interest, or the next succeeding Business Day if such date is not a Business
Day. At least 15 days before the special record date, the Company shall mail or cause to be mailed to each Securityholder, with a copy
to the Trustee, a notice that states the special record date, the payment date and the amount of defaulted interest, and interest payable
on such defaulted interest, if any, to be paid.

 

Except as otherwise specified
as contemplated by Section 2.2 for Securities of any Series, interest on the Securities of each Series shall be computed on the basis
of a 360-day year of twelve 30-day months.

 

	2.14.	CUSIP NUMBER.

 

The Company in issuing
the Securities may use one or more “CUSIP” numbers, and, if the Company does so, the Trustee shall use the CUSIP number(s)
in notices of redemption or exchange as a convenience to Holders, PROVIDED, that any such notice may state that no representation is made
as to the correctness or accuracy of the CUSIP number(s) printed in the notice or on the Securities, and that reliance may be placed only
on the other identification numbers printed on the Securities, and that any such redemption or exchange shall not be affected by any defect
in or omission of any such numbers.

 

	2.15.	PROVISIONS FOR GLOBAL SECURITIES.

 

(a) A Board Resolution,
a supplemental indenture hereto or an Officers’ Certificate shall establish whether the Securities of a Series shall be issued in
whole or in part in the form of one or more Global Securities, and the Depository for such Global Securities or Securities.

 

(b) Notwithstanding any
provisions to the contrary contained in Section 2.7 and in addition thereto, if, and only if the Depository (i) at any time is unwilling
or unable to continue as Depository for such Global Security or ceases to be a clearing agency registered under the Exchange Act and (ii) a
successor Depository is not appointed by the Company within 90 days after the date the Company is so informed in writing or becomes aware
of the same, the Company promptly will execute and deliver to the Trustee definitive Securities, and the Trustee, upon receipt of a Company
Request for the authentication and delivery of such definitive Securities (which the Company will promptly execute and deliver to the
Trustee) and an Officers’ Certificate to the effect that such Global Security shall be so exchangeable, will authenticate and deliver
definitive Securities, without charge, registered in such names and in such authorized denominations as the Depository shall direct in
writing (pursuant to instructions from its direct and indirect participants or otherwise) in an aggregate principal amount equal to the
principal amount of the Global Security with like tenor and terms. Upon the exchange of a Global Security for definitive Securities, such
Global Security shall be canceled by the Trustee. Unless and until it is exchanged in whole or in part for definitive Securities, as provided
in this Section 2.15(b), a Global Security may not be transferred except as a whole by the Depository with respect to such Global
Security to a nominee of such Depository, by a nominee of such Depository to such Depository or another nominee of such Depository or
by the Depository or any such nominee to a successor Depository or a nominee of such a successor Depository.

 

    11

    	 

    

 

(c) Any Global Security
issued hereunder shall bear a legend in substantially the following form:

 

“This Security is a Global
Security within the meaning of the Indenture hereinafter referred to, and is registered in the name of the Depository or a nominee of
the Depository. This Security is exchangeable for Securities registered in the name of a Person other than the Depository or its nominee
only in the limited circumstances described in the Indenture, and may not be transferred except as a whole by the Depository to a nominee
of the Depository, by a nominee of the Depository to the Depository or another nominee of the Depository or by the Depository or any such
nominee to a successor Depository or a nominee of such a successor Depository.”

 

(d) The Depository, as
a Holder, may appoint agents and otherwise authorize participants to give or take any request, demand, authorization, direction, notice,
consent, waiver or other action which a Holder is entitled to give or take under the Indenture.

 

(e) Notwithstanding the
other provisions of this Indenture, unless otherwise specified as contemplated by Section 2.2, payment of the principal of, and interest
and premium, if any, on, any Global Security shall be made to the Depository or its nominee in its capacity as the Holder thereof.

 

(f) Except as provided
in Section 2.15(e) above, the Company, the Trustee and any Agent shall treat a Person as the Holder of such principal amount of outstanding
Securities of any Series represented by a Global Security as shall be specified in a written statement of the Depository (which may be
in the form of a participants’ list for such Series) with respect to such Global Security, for purposes of obtaining any consents,
declarations, waivers or directions required to be given by the Holders pursuant to this Indenture, PROVIDED, that until the Trustee is
so provided with a written statement, it may treat the Depository or any other Person in whose name a Global Security is registered as
the owner of such Global Security for the purpose of receiving payment of the principal of, and any premium and (subject to Section 2.13)
any interest on, such Global Security and for all other purposes whatsoever, and none of the Company, the Trustee or any agent of the
Company or the Trustee shall be affected by notice to the contrary.

 

	2.16.	PERSONS DEEMED OWNERS.

 

Prior to due presentment
of a Security for registration of transfer, the Company, the Trustee, the Registrar and any agent of the Company, the Registrar or the
Trustee may treat the Person in whose name such Security is registered as the owner of such Security for the purpose of receiving payment
of the principal of, and any premium and (subject to Section 2.13) any interest on, such Security and for all other purposes whatsoever,
and none of the Company, the Trustee, the Registrar or any agent of the Company, the Trustee or the Registrar shall be affected by notice
to the contrary.

 

ARTICLE 3

 

REDEMPTION

 

	3.1.	NOTICES TO TRUSTEE.

 

The Company may, with
respect to any Series of Securities, reserve the right to redeem and pay the Series of Securities, or may covenant to redeem and pay the
Series of Securities or any part thereof, prior to the Stated Maturity thereof at such time and on such terms as provided for in such
Securities or the related Board Resolution, supplemental indenture or Officers’ Certificate. If a Series of Securities is redeemable
and the Company elects to redeem all or part of such Series of Securities, it shall notify the Trustee of the Redemption Date and the
principal amount of Securities to be redeemed at least 45 days (unless a shorter notice shall be satisfactory to the Trustee) before the
Redemption Date. Any such notice may be canceled at any time prior to notice of such redemption being mailed to any Holder, and shall
thereby be void and of no effect.

 

	3.2.	SELECTION BY TRUSTEE OF SECURITIES TO BE REDEEMED.

 

Unless otherwise indicated
for a particular Series of Securities by a Board Resolution, a supplemental indenture or an Officers’ Certificate, if fewer than
all of the Securities of a Series are to be redeemed, the Trustee shall select the Securities of a Series to be redeemed pro rata, by
lot or by any other method that the Trustee considers fair and appropriate (unless the Company specifically directs the Trustee otherwise)
and, if such Securities are listed on any securities exchange, by a method that complies with the requirements of such exchange.

 

    12

    	 

    

 

The Trustee shall make
the selection from Securities of a Series outstanding and not previously called for redemption, and shall promptly notify the Company
in writing of the Securities selected for redemption and, in the case of any Security selected for partial redemption, the principal amount
thereof to be redeemed at least 35 but not more than 60 days before the Redemption Date. Securities of a Series in denominations of $1,000
may be redeemed only in whole. The Trustee may select for redemption portions of the principal of Securities of a Series that have denominations
larger than $1,000. Securities of a Series and portions of them it selects shall be in amounts of $1,000 or, with respect to Securities
of any Series issuable in other denominations pursuant to Section 2.2(10), the minimum principal denomination for each Series and integral
multiples thereof. Provisions of this Indenture that apply to Securities called for redemption also apply to portions of Securities called
for redemption.

 

	3.3.	NOTICE OF REDEMPTION.

 

Unless otherwise indicated
for a particular Series by Board Resolution, a supplemental indenture hereto or an Officers’ Certificate, at least 30 days, and
no more than 60 days, before a Redemption Date, the Company shall mail, or cause to be mailed, a notice of redemption by first-class mail
to each Holder of Securities to be redeemed at his or her last address as the same appears on the registry books maintained by the Registrar.
The notice shall identify the Securities to be redeemed and shall state:

 

(1) the Redemption Date;

 

(2) the redemption price,
and that such redemption price shall become due and payable on the Redemption Date;

 

(3) if any Security of
a Series is being redeemed in part, the portion of the principal amount of such Security of a Series to be redeemed and that, after the
Redemption Date and upon surrender of such Security of a Series, a new Security or Securities in principal amount equal to the unredeemed
portion will be issued;

 

(4) the name and address
of the Paying Agent;

 

(5) that Securities of
a Series called for redemption must be surrendered to the Paying Agent to collect the redemption price, and the place or places where
each such Security is to be surrendered for such payment;

 

(6) that, unless the
Company defaults in making the redemption payment, interest on the Securities of a Series called for redemption ceases to accrue on the
Redemption Date, and the only remaining right of the Holders of such Securities is to receive payment of the redemption price upon surrender
to the Paying Agent of the Securities redeemed;

 

(7) if fewer than all
of the Securities of a Series are to be redeemed, the identification of the particular Securities of a Series (or portion thereof) to
be redeemed, as well as the aggregate principal amount of Securities of a Series to be redeemed and the aggregate principal amount of
Securities of a Series to be outstanding after such partial redemption.

 

(8) the CUSIP number,
if any, printed on the Securities being redeemed; and

 

(9) that no representation
is made as to the correctness or accuracy of the CUSIP number, if any, listed in such notice or printed on the Securities.

 

At the Company’s
request, the Trustee shall give the notice of redemption in the Company’s name and at the Company’s sole expense.

 

    13

    	 

    

 

	3.4.	EFFECT OF NOTICE OF REDEMPTION.

 

Once the notice of redemption
described in Section 3.3 is mailed, Securities of a Series called for redemption become due and payable on the Redemption Date and at
the redemption price, plus interest, if any, accrued to the Redemption Date. Upon surrender to the Trustee or Paying Agent, such Securities
of a Series shall be paid at the redemption price, plus accrued interest, if any, to the Redemption Date; PROVIDED, that if the Redemption
Date is after a regular interest payment record date and on or prior to the next Interest Payment Date, the accrued interest shall be
payable to the Holder of the redeemed Securities registered on the relevant record date, as specified by the Company in the notice to
the Trustee pursuant to Section 3.1.

 

	3.5.	DEPOSIT OF REDEMPTION PRICE.

 

On or prior to the Redemption
Date (but no later than 11:00 A.M. Eastern Time on such date), the Company shall deposit with the Paying Agent money sufficient to pay
the redemption price of and accrued interest, if any, on all Securities to be redeemed on that date other than Securities or portions
thereof called for redemption on that date which have been delivered by the Company to the Trustee for cancellation.

 

On and after any Redemption
Date, if money sufficient to pay the redemption price of, and accrued interest on, Securities called for redemption shall have been made
available in accordance with the preceding paragraph and the Company and the Paying Agent are not prohibited from paying such moneys to
Holders, the Securities called for redemption will cease to accrue interest and the only right of the Holders of such Securities will
be to receive payment of the redemption price of and, subject to the proviso in Section 3.4, accrued and unpaid interest on such
Securities to the Redemption Date. If any Security called for redemption shall not be so paid, interest will be paid, from the Redemption
Date until such redemption payment is made, on the unpaid principal of the Security and any interest or premium, if any, not paid on such
unpaid principal, in each case, at the rate and in the manner provided in the Securities.

 

	3.6.	SECURITIES REDEEMED IN PART.

 

Upon surrender of a Security
of a Series that is redeemed in part, the Company shall execute, and the Trustee shall authenticate, for a Holder a new Security of the
same Series equal in principal amount to the unredeemed portion of the Security surrendered.

 

ARTICLE 4

 

COVENANTS

 

	4.1.	PAYMENT OF SECURITIES.

 

The Company shall pay
the principal of, and interest and premium, if any, on, each Series of Securities on the dates and in the manner provided in such Securities
and this Indenture.

 

An installment of principal
or interest shall be considered paid on the date it is due if the Trustee or Paying Agent holds on that date money designated for and
sufficient to pay such installment and is not prohibited from paying such money to the Holders pursuant to the terms of this Indenture
or otherwise.

 

The Company shall pay
interest on overdue principal, and overdue interest, to the extent lawful, at the rate specified in the Series of Securities.

 

	4.2.	SEC REPORTS.

 

The Company will deliver
to the Trustee within 15 days after the filing of the same with the SEC, copies of the quarterly and annual reports and of the information,
documents and other reports, if any, which the Company is required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange
Act; PROVIDED, HOWEVER, that each such report or document will be deemed to be so delivered to the Trustee if the Company files such report
or document with the SEC through the SEC’s EDGAR database no later than the time such report or document is required to be filed
with the SEC pursuant to the Exchange Act. Notwithstanding that the Company may not be subject to the reporting requirements of Section
13 or 15(d) of the Exchange Act, the Company will file with the SEC, to the extent permitted, and provide the Trustee with, such quarterly
and annual reports and such information, documents and other reports specified in Sections 13 and 15(d) of the Exchange Act. The Company
will also comply with the other provisions of TIA Section 314(a).

 

    14

    	 

    

  

	4.3.	WAIVER OF STAY, EXTENSION OR USURY LAWS.

 

The Company covenants
(to the extent that it may lawfully do so) that it will not at any time insist upon, or plead (as a defense or otherwise) or in any manner
whatsoever claim or take the benefit or advantage of, any stay, extension, usury or other law which would prohibit or forgive the Company
from paying all or any portion of the principal of, and/or interest and premium, if any, on, the Securities as contemplated herein, wherever
enacted, now or at any time hereafter in force, or which may affect the covenants or the performance of this Indenture; and the Company
hereby expressly waives (to the extent that they may lawfully do so) all benefit or advantage of any such law, and covenants that it will
not hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every
such power as though no such law had been enacted.

 

	4.4.	COMPLIANCE CERTIFICATE.

 

(a) The Company shall
deliver to the Trustee, within 120 days after the end of each fiscal year of the Company, an Officers’ Certificate which complies
with TIA Section 314(a)(4) stating that a review of the activities of the Company and its Subsidiaries during such fiscal year has been
made under the supervision of the signing Officers with a view to determining whether the Company has kept, observed, performed and fulfilled
its obligations under this Indenture, and further stating, as to each such Officer signing such certificate, that to the best of his or
her knowledge the Company has kept, observed, performed and fulfilled each and every covenant contained in this Indenture and that there
is no default in the performance or observance of any of the terms, provisions and conditions hereof (or, if a Default or Event of Default
shall have occurred, describing all such Defaults or Events of Default of which he or she may have knowledge and what action the Company
is taking or proposes to take with respect thereto) and that to the best of his or her knowledge no event has occurred and remains in
existence by reason of which payments on account of the principal of, or interest or premium, if any, on, the Securities is prohibited,
or if such event has occurred, a description of the event and what action the Company is taking or proposes to take with respect thereto.

 

(b) (i) If any Default
or Event of Default has occurred and is continuing or (ii) if any Holder seeks to exercise any remedy hereunder with respect to a claimed
Default under this Indenture or the Securities, within five Business Days after the Company becoming aware of such occurrence the Company
shall deliver to the Trustee an Officers’ Certificate specifying such event, notice or other action and what action the Company
is taking or proposes to take with respect thereto.

 

	4.5.	CORPORATE EXISTENCE.

 

Subject to Article 5,
the Company shall do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence, in
accordance with the organizational documents (as the same may be amended from time to time) of the Company and the rights (charter and
statutory), licenses and franchises of the Company; PROVIDED, HOWEVER, that the Company shall not be required to preserve any such right,
license or franchise, or its corporate existence, if the Board of Directors shall determine that the preservation thereof is no longer
desirable in the conduct of the business of the Company and that the loss thereof is not adverse in any material respect to the Holders.

 

    15

    	 

    

 

ARTICLE 5

 

SUCCESSOR CORPORATION

 

	5.1.	LIMITATION ON CONSOLIDATION, MERGER AND SALE OF ASSETS.

 

(a) The Company will
not, in any transaction or series of transactions, merge or consolidate with or into, or sell, assign, convey, transfer, lease or otherwise
dispose of all or substantially all of its properties and assets (as an entirety or substantially as an entirety in one transaction or
a series of related transactions), to any Person or Persons, unless at the time of and after giving effect thereto (i) either (A) if
the transaction or series of transactions is a merger or consolidation, the Company shall be the surviving Person of such merger or consolidation,
or (B) the Person formed by such consolidation or into which the Company is merged or to which the properties and assets of the Company
are transferred (any such surviving Person or transferee Person being the “Surviving Entity”) shall be a corporation organized
and existing under the laws of the United States of America, any state thereof or the District of Columbia, or a corporation or comparable
legal entity organized under the laws of a foreign jurisdiction and shall expressly assume by a supplemental indenture executed and delivered
to the Trustee, in form reasonably satisfactory to the Trustee, all of the obligations of the Company (including, without limitation,
the obligation to pay the principal of, and premium and interest, if any, on, the Securities and the performance of the other covenants)
under the Securities of each Series and this Indenture, and in each case, this Indenture shall remain in full force and effect; and (ii) immediately
before and immediately after giving effect to such transaction or series of transactions on a pro forma basis (including, without limitation,
any Indebtedness incurred or anticipated to be incurred in connection with or in respect of such transaction or series of transactions),
no Default or Event of Default shall have occurred and be continuing.

 

(b) In connection with
any consolidation, merger or transfer of assets contemplated by this Section 5.1, the Company shall deliver, or cause to be delivered,
to the Trustee, in form and substance reasonably satisfactory to the Trustee, an Officers’ Certificate and an Opinion of Counsel,
each stating that such consolidation, merger or transfer, and the supplemental indenture in respect thereto, comply with this Section
5.1, and that all conditions precedent herein provided for relating to such transaction or transactions have been complied with.

 

	5.2.	SUCCESSOR PERSON SUBSTITUTED.

 

Upon any consolidation,
merger or transfer of all or substantially all of the assets of the Company in accordance with Section 5.1 above, the successor corporation
formed by such consolidation, or into which the Company is merged or to which such transfer is made, shall succeed to, and be substituted
for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such successor corporation
had been named as the Company herein, and thereafter (except with respect to any such transfer which is a lease) the predecessor corporation
shall be relieved of all obligations and covenants under this Indenture and the Securities.

 

ARTICLE 6

 

DEFAULTS AND REMEDIES

 

	6.1.	EVENTS OF DEFAULT.

 

“Events of Default,”
wherever used herein with respect to Securities of any Series, means any one of the following events, unless in the establishing Board
Resolution, supplemental indenture or Officers’ Certificate, it is provided that such Series shall not have the benefit of said
Event of Default:

 

(1) there is a default
in the payment of any principal of, or premium, if any, on, the Securities when the same becomes due and payable at Maturity, upon acceleration,
redemption or otherwise;

 

(2) there is a default
in the payment of any interest on any Security of a Series when the same becomes due and payable, and the Default continues for a period
of 30 days;

 

(3) the Company defaults
in the observance or performance of any other covenant in the Securities of a Series or in this Indenture for 60 days after written notice
from the Trustee or the Holders of not less than 25% in the aggregate principal amount of the Securities of such Series then outstanding,
which notice must specify the Default, demand that it be remedied and state that the notice is a “Notice of Default”;

 

    16

    	 

    

 

(4) the Company or any
Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law:

 

(A) commences
a voluntary case,

 

(B) consents
to the entry of an order for relief against it in an involuntary case,

 

(C) consents
to the appointment of a Custodian of it or for all or substantially all of its property,

 

(D) makes
a general assignment for the benefit of its creditors, or

 

(E) generally
is not paying its debts as they become due;

 

(5) a court of competent
jurisdiction enters an order or decree under any Bankruptcy Law that:

 

(A) is for
relief against the Company or any Significant Subsidiary in an involuntary case;

 

(B) appoints
a Custodian of the Company or any Significant Subsidiary, or for all or substantially all of the property of the Company or any Significant
Subsidiary; or

 

(C) orders
the liquidation of the Company or any Significant Subsidiary, and the order or decree remains unstayed and in effect for 90 consecutive
days; or

 

(6) any other Event of
Default provided with respect to Securities of that Series, which is specified in a Board Resolution, a supplemental indenture hereto
or an Officers’ Certificate, in accordance with Section 2.2(19).

 

The term “Bankruptcy
Law” means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors. The term “Custodian”
means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.

 

The Trustee may withhold
notice of any Default (except in the payment of the principal of, or interest or premium, if any, on, the Securities) to the Holders of
the Securities of any Series in accordance with Section 7.5. When a Default is cured, it ceases to exist.

 

	6.2.	ACCELERATION.

 

If an Event of Default
with respect to Securities of any Series at the time outstanding (other than an Event of Default arising under Section 6.1(4) or (5))
occurs and is continuing, the Trustee by written notice to the Company, or the Holders of not less than 25% in aggregate principal amount
of the Securities of that Series then outstanding by written notice to the Company and the Trustee, may declare that the entire principal
amount of all the Securities of that Series then outstanding plus accrued and unpaid interest to the date of acceleration are immediately
due and payable, in which case such amounts shall become immediately due and payable; PROVIDED, HOWEVER, that after such acceleration
but before a judgment or decree based on such acceleration is obtained by the Trustee, the Holders of a majority in aggregate principal
amount of the outstanding Securities of that Series may rescind and annul such acceleration and its consequences if (i) all existing
Events of Default, other than the nonpayment of accelerated principal, interest or premium, if any, that has become due solely because
of the acceleration, have been cured or waived, (ii) to the extent the payment of such interest is lawful, interest on overdue installments
of interest and overdue principal, which has become due otherwise than by such declaration of acceleration, has been paid and (iii) the
rescission would not conflict with any judgment or decree. No such rescission shall affect any subsequent Default or impair any right
consequent thereto. In case an Event of Default specified in Section 6.1(4) or (5) with respect to the Company occurs, such principal,
premium, if any, and interest amount with respect to all of the Securities of that Series shall be due and payable immediately without
any declaration or other act on the part of the Trustee or the Holders of the Securities of that Series.

 

	6.3.	REMEDIES.

 

If an Event of Default
with respect to Securities of any Series at the time outstanding occurs and is continuing, the Trustee may pursue any available remedy
by proceeding at law or in equity to collect the payment of the principal of, or interest and premium, if any, on, the Securities of that
Series, or to enforce the performance of any provision of the Securities of that Series or this Indenture.

 

The Trustee may maintain
a proceeding even if it does not possess any of the Securities of that Series or does not produce any of them in the proceeding. A delay
or omission by the Trustee or any Securityholder in exercising any right or remedy accruing upon an Event of Default shall not impair
the right or remedy or constitute a waiver of or acquiescence in the Event of Default. No remedy is exclusive of any other remedy. All
available remedies are cumulative to the extent permitted by law.

 

    17

    	 

    

 

	6.4.	WAIVER OF PAST DEFAULTS AND EVENTS OF DEFAULT.

 

Subject to Sections 6.2,
6.7 and 8.2, the Holders of a majority in principal amount of the Securities of any Series then outstanding have the right to waive any
existing Default or Event of Default with respect to such Series or compliance with any provision of this Indenture (with respect to such
Series) or the Securities of such Series. Upon any such waiver, such Default with respect to such Series shall cease to exist, and any
Event of Default with respect to such Series arising therefrom shall be deemed to have been cured for every purpose of this Indenture;
but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereto. This Section 6.4
shall be in lieu of TIA Section 316(a)(1)(B), and TIA Section 316(a)(1)(B) is hereby expressly excluded from this Indenture
and Section as permitted by the TIA.

 

	6.5.	CONTROL BY MAJORITY.

 

Subject to Sections 6.2,
6.7 and 8.2, the Holders of a majority in principal amount of the Securities of any Series then outstanding may direct the time, method
and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on the Trustee
by this Indenture with respect to such Series. The Trustee, however, may refuse to follow any direction that conflicts with law or this
Indenture, or that the Trustee determines may be unduly prejudicial to the rights of another Securityholder, or that may involve the Trustee
in personal liability; PROVIDED, that the Trustee may take any other action deemed proper by the Trustee which is not inconsistent with
such direction. This Section 6.5 shall be in lieu of TIA Section 316(a)(1)(A), and TIA Section 316(a)(1)(A) is hereby expressly excluded
from this Indenture and Section as permitted by the TIA.

 

	6.6.	LIMITATION ON SUITS.

 

Subject to Section 6.7,
a Securityholder may not institute any proceeding or pursue any remedy with respect to this Indenture or the Securities of a Series unless:

 

(1) the Holder gives
to the Trustee written notice of a continuing Event of Default with respect to the Securities of that Series;

 

(2) the Holders of at
least 25% in aggregate principal amount of the Securities of such Series then outstanding make a written request to the Trustee to pursue
the remedy;

 

(3) such Holder or Holders
offer to the Trustee indemnity reasonably satisfactory to the Trustee against any loss, liability or expense to be incurred in compliance
with such request;

 

(4) the Trustee does
not comply with the request within 60 days after receipt of the request and the offer of indemnity; and

 

    18

    	 

    

 

(5) no direction inconsistent
with such written request has been given to the Trustee during such 60-day period by the Holders of a majority in aggregate principal
amount of the Securities of such Series then outstanding.

 

A Securityholder may
not use this Indenture to prejudice the rights of another Securityholder, or to obtain a preference or priority over another Securityholder.

 

	6.7.	RIGHTS OF HOLDERS TO RECEIVE PAYMENT.

 

Notwithstanding any other
provision of this Indenture, the right of any Holder of a Security of a Series to receive payment of the principal of, and interest and
premium, if any, on, the Security of such Series on or after the respective due dates expressed in the Security of such Series, or to
bring suit for the enforcement of any such payment on or after such respective dates, is absolute and unconditional, and shall not be
impaired or affected without the consent of the Holder.

 

	6.8.	COLLECTION SUIT BY TRUSTEE.

 

If an Event of Default
in payment of principal, interest or premium, if any, specified in Section 6.1(1) or (2) with respect to Securities of any Series at the
time outstanding occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against
the Company (or any other obligor on the Securities of that Series) for the whole amount of unpaid principal and premium, if any, and
accrued interest remaining unpaid, together with interest on overdue principal and premium, if any, and, to the extent that payment of
such interest is lawful, interest on overdue installments of interest, in each case at the rate then borne by the Securities of that Series,
and such further amounts as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation,
expenses, disbursements and advances of the Trustee, its agents and counsel, as set forth in Section 7.7.

 

	6.9.	TRUSTEE MAY FILE PROOFS OF CLAIM.

 

The Trustee may file
such proofs of claim and other papers or documents, and take other actions (including sitting on a committee of creditors), as may be
necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements
and advances of the Trustee, its agents and counsel) and the Securityholders allowed in any judicial proceedings relative to the Company
(or any other obligor on the Securities), any of their respective creditors or any of their respective property, and the Trustee shall
be entitled and empowered to collect and receive any monies or other property payable or deliverable on any such claims, and to distribute
the same after deduction of its charges and expenses to the extent that any such charges and expenses are not paid out of the estate in
any such proceedings, and any custodian in any such judicial proceeding is hereby authorized by each Securityholder to make such payments
to the Trustee, and in the event that the Trustee shall consent to the making of such payments directly to the Securityholders, to pay
to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and
counsel, and any other amounts due the Trustee under Section 7.7.

 

Nothing herein contained
shall be deemed to authorize the Trustee to authorize or consent to, or accept or adopt on behalf of any Securityholder, any plan of reorganization,
arrangement, adjustment or composition affecting the Securities of a Series or the rights of any Holder thereof, or to authorize the Trustee
to vote in respect of the claim of any Securityholder in any such proceedings.

 

	6.10.	PRIORITIES.

 

If the Trustee collects
any money pursuant to this Article 6, it shall pay out the money in the following order:

 

FIRST: to the Trustee for amounts
due under Section 7.7;

 

SECOND: to Securityholders for
amounts then due and unpaid for the principal of, and interest and premium, if any, on, the Securities in respect of which, or for the
benefit of which, such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and
payable on such Securities; for principal and any premium and interest, respectively; and

 

    19

    	 

    

 

THIRD: to the Company.

 

The Trustee may fix a
record date and payment date for any payment to Securityholders pursuant to this Section 6.10. At least 15 days before such record date,
the Trustee shall mail to each Securityholder a notice that states the record date, the payment date and amount to be paid.

 

	6.11.	UNDERTAKING FOR COSTS.

 

In any suit for the enforcement
of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken or omitted by it as Trustee, a court
in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court
in its discretion may assess reasonable costs, including reasonable attorneys’ fees, against any party litigant in the suit, having
due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section 6.11 does not apply to a suit
by the Trustee, a suit by a Holder pursuant to Section 6.7 or a suit by Holders of more than 10% in principal amount of the Securities
of a Series then outstanding.

 

ARTICLE 7

 

TRUSTEE

 

	7.1.	DUTIES OF TRUSTEE.

 

(a) If an Event of Default
has occurred and is continuing, the Trustee shall exercise such of the rights and powers vested in it by this Indenture and use the same
degree of care and skill in their exercise as a prudent Person would exercise or use under the same circumstances in the conduct of his
own affairs.

 

(b) Except during the
continuance of an Event of Default:

 

(1) The Trustee need
perform only those duties that are specifically set forth in this Indenture, and no covenants or obligations shall be implied in this
Indenture against the Trustee.

 

(2) In the absence of
bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed
therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture, but, in the case
of any such certificates or opinions which by any provision hereof are specifically required to be furnished to the Trustee, the Trustee
shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture.

 

(c) The Trustee may not
be relieved from liability for its own negligent action, its own negligent failure to act or its own willful misconduct, except that:

 

(1) This paragraph does
not limit the effect of paragraph (b) of this Section 7.1.

 

(2) The Trustee shall
not be liable for any error of judgment made in good faith by a Responsible Officer, unless it is proved that the Trustee was negligent
in ascertaining the pertinent facts.

 

(3) The Trustee shall
not be liable with respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant
to Sections 6.2 and 6.5.

 

(d) No provision of this
Indenture shall require the Trustee to expend or risk its own funds, or otherwise incur any financial liability, in the performance of
any of its rights or powers if it shall have reasonable grounds for believing that repayment of such funds or adequate indemnity satisfactory
to it against such risk or liability is not reasonably assured to it.

 

(e) Whether or not therein
expressly so provided, paragraphs (a), (b), (c) and (d) of this Section 7.1 shall govern every provision of this Indenture that in any
way relates to the Trustee.

 

    20

    	 

    

 

(f) The Trustee and Paying
Agent shall not be liable for interest on any money received by either of them, except as the Trustee and Paying Agent may agree in writing
with the Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by the law.

 

(g) The Paying Agent,
the Registrar and any authenticating agent shall be entitled to the protections, immunities and standard of care set forth in paragraphs
(a), (b), (c), (d) and (f) of this Section 7.1 and in Section 7.2 with respect to the Trustee.

 

	7.2.	RIGHTS OF TRUSTEE.

 

(a) Subject to Section
7.1:

 

(1) The Trustee may rely
on, and shall be protected in acting or refraining from acting upon, any document reasonably believed by it to be genuine and to have
been signed or presented by the proper Person. The Trustee need not investigate any fact or matter stated in the document.

 

(2) Before the Trustee
acts or refrains from acting, it may require an Officers’ Certificate or an Opinion of Counsel, or both, which shall conform to
the provisions of Section 10.5. The Trustee shall be protected and shall not be liable for any action it takes or omits to take in good
faith in reliance on such certificate or opinion.

 

(3) The Trustee may act
through agents and attorneys, and shall not be responsible for the misconduct or negligence of any agent appointed by it with due care.

 

(4) The Trustee shall
not be liable for any action it takes or omits to take in good faith which it reasonably believes to be authorized or within its rights
or powers.

 

(5) The Trustee may consult
with counsel reasonably acceptable to the Trustee, which may be counsel to the Company, and the advice or opinion of such counsel as to
matters of law shall be full and complete authorization and protection from liability in respect of any action taken, omitted or suffered
by it hereunder in good faith and in accordance with the advice or opinion of such counsel.

 

(6) The Trustee shall
be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request, order or direction of any
of the Holders pursuant to the provisions of this Indenture, unless such Holders shall have offered to the Trustee reasonable security
or indemnity against the costs, expenses and liabilities which may be incurred therein or thereby.

 

(7) The Trustee shall
not be deemed to have knowledge of any fact or matter (including, without limitation, a Default or Event of Default) unless such fact
or matter is known to a Responsible Officer of the Trustee.

 

(8) Unless otherwise
expressly provided herein or in the Securities of a Series or the related Board Resolution, supplemental indenture or Officers’
Certificate, the Trustee shall not have any responsibility with respect to reports, notices, certificates or other documents filed with
it hereunder, except to make them available for inspection, at reasonable times, by Securityholders, it being understood that delivery
of such reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of such shall
not constitute constructive notice of any information contained therein or determinable from information contained therein, including
the Company’s compliance with any of its covenants hereunder (except as set forth in Section 4.4).

 

    21

    	 

    

 

	7.3.	INDIVIDUAL RIGHTS OF TRUSTEE.

 

The Trustee in its individual
or any other capacity may become the owner or pledgee of Securities, and may make loans to, accept deposits from, perform services for
or otherwise deal with the Company, or any Affiliate thereof, with the same rights it would have if it were not Trustee. Any Agent may
do the same with like rights. The Trustee, however, shall be subject to Sections 7.10 and 7.11.

 

	7.4.	TRUSTEE’S DISCLAIMER.

 

The Trustee makes no
representation as to the validity or adequacy of this Indenture or the Securities (except that the Trustee represents that it is duly
authorized to execute and deliver this Indenture and authenticate the Securities and perform its obligations hereunder), and the Trustee
shall not be accountable for the Company’s use of the proceeds from the sale of Securities or any money paid to the Company pursuant
to the terms of this Indenture, and the Trustee shall not be responsible for any statement in the Securities other than its certificates
of authentication.

 

	7.5.	NOTICE OF DEFAULT.

 

If a Default or an Event
of Default occurs and is continuing with respect to the Securities of any Series, and if it is known to the Trustee, the Trustee shall
mail to each Securityholder of the Securities of that Series notice of the Default or the Event of Default, as the case may be, within
90 days after it occurs or, if later, after a Responsible Officer of the Trustee has knowledge of such Default or Event of Default (except
if such Default or Event of Default has been validly cured or waived before the giving of such notice). Except in the case of a Default
or an Event of Default in payment of the principal of, or interest or premium, if any, on, any Security of any Series, the Trustee may
withhold the notice if and so long as the Board of Directors of the Trustee, the executive committee or any trust committee of such board
and/or its Responsible Officers in good faith determine(s) that withholding the notice is in the interests of the Securityholders of that
Series.

 

	7.6.	REPORTS BY TRUSTEE TO HOLDERS.

 

If and to the extent
required by the TIA, within 60 days after April 1 of each year, commencing the April 1 following the date of this Indenture, the
Trustee shall mail to each Securityholder a brief report dated as of such April 1 that complies with TIA Section 313(a). The Trustee also
shall comply with TIA Sections 313(b) and 313(c).

 

A copy of each report
at the time of its mailing to Securityholders shall be filed with the SEC and any stock exchange on which the Securities of that Series
are listed. The Company shall promptly notify the Trustee when the Securities of any Series are listed on any stock exchange or any delisting
thereof, and the Trustee shall comply with TIA Section 313(d).

 

	7.7.	COMPENSATION AND INDEMNITY.

 

The Company shall pay
to the Trustee from time to time reasonable compensation for its services. The Trustee’s compensation shall not be limited by any
provision of law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee within 45 days after receipt
of request for all reasonable out-of-pocket disbursements and expenses incurred or made by it in connection with its duties under this
Indenture, including the reasonable compensation, disbursements and expenses of the Trustee’s agents and counsel.

 

The Company shall indemnify
the Trustee for, and hold it harmless against, any and all loss or liability incurred by it in connection with the acceptance or performance
of its duties under this Indenture including the reasonable costs and expenses of defending itself against any claim or liability in connection
with the exercise or performance of any of its powers or duties hereunder. The Trustee shall notify the Company promptly of any claim
asserted against the Trustee for which it may seek indemnity.

 

The failure by the Trustee
to so notify the Company shall not however relieve the Company of its obligations. Notwithstanding the foregoing, the Company need not
reimburse the Trustee for any expense or indemnify it against any loss or liability incurred by the Trustee through its negligence or
bad faith. To secure the payment obligations of the Company in this Section 7.7, the Trustee shall have a lien prior to the Securities
of any Series on all money or property held or collected by the Trustee except such money or property held in trust to pay the principal
of, interest and premium, if any, on particular Securities of that Series.

 

    22

    	 

    

 

When the Trustee incurs
expenses or renders services after an Event of Default specified in Section 6.1(4) or (5) occurs, the expenses and the compensation for
the services are intended to constitute expenses of administration under any Bankruptcy Law.

 

For purposes of this
Section 7.7, the term “Trustee” shall include any trustee appointed pursuant to this Article 7.

 

	7.8.	REPLACEMENT OF TRUSTEE.

 

The Trustee may resign
with respect to the Securities of one or more Series by so notifying the Company in writing at least 90 days in advance of such resignation.

 

The Holders of a majority
in principal amount of the outstanding Securities of any Series may remove the Trustee with respect to that Series by notifying the removed
Trustee in writing and may appoint a successor Trustee with respect to that Series with the consent of the Company, which consent shall
not be unreasonably withheld. The Company may remove the Trustee with respect to that Series at its election if:

 

(1) the Trustee fails
to comply with, or ceases to be eligible under, Section 7.10;

 

(2) the Trustee is adjudged
a bankrupt or an insolvent, or an order for relief is entered with respect to the Trustee, under any Bankruptcy Law;

 

(3) a Custodian or other
public officer takes charge of the Trustee or its property; 

 

(4) the Trustee otherwise
becomes incapable of acting; or

 

(5) If the Trustee resigns
or is removed, or if a vacancy exists in the office of Trustee, with respect to any Series of Securities for any reason, the Company shall
promptly appoint, by Board Resolution, a successor Trustee.

 

If a successor Trustee
with respect to the Securities of one or more Series does not take office within 60 days after the retiring Trustee resigns or is removed,
the retiring Trustee, the Company or the Holders of at least 10% in principal amount of the outstanding Securities of the applicable Series
may petition any court of competent jurisdiction for the appointment of a successor Trustee.

 

If the Trustee with respect
to the Securities of one or more Series fails to comply with Section 7.10, any Securityholder of the applicable Series may petition any
court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee.

 

A successor Trustee shall
deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Immediately following such delivery, (i) the
retiring Trustee with respect to one or more Series shall, subject to its rights under Section 7.7, transfer all property held by it as
Trustee with respect to such Series to the successor Trustee, (ii) the resignation or removal of the retiring Trustee shall become effective
and (iii) the successor Trustee with respect to such Series shall have all the rights, powers and duties of the Trustee under this Indenture.
A successor Trustee with respect to the Securities of one or more Series shall mail notice of its succession to each Securityholder of
such Series.

 

	7.9.	SUCCESSOR TRUSTEE BY CONSOLIDATION, MERGER OR CONVERSION.

 

If the Trustee, or any
Agent, consolidates with, merges or converts into, or transfers all or substantially all of its corporate trust assets to, another corporation,
subject to Section 7.10, the successor corporation without any further act shall be the successor Trustee or Agent, as the case may be.

 

	7.10.	ELIGIBILITY; DISQUALIFICATION.

 

This Indenture shall
always have a Trustee who satisfies the requirements of TIA Sections 310(a)(1), (2) and (5) in every respect. The Trustee (or in the case
of a Trustee that is a Person included in a bank holding company system, the related bank holding company) shall have a combined capital
and surplus of at least $100,000,000 as set forth in its most recent published annual report of condition. The Trustee shall comply with
TIA Section 310(b), including the provision in Section 310(b)(1). In addition, if the Trustee is a Person included in a bank holding company
system, the Trustee, independently of such bank holding company, shall meet the capital requirements of TIA Section 310(a)(2). If at any
time the Trustee shall cease to be eligible in accordance with the provisions of this Section 7.10, it shall resign immediately in
the manner and with the effect specified in this Article 7.

 

    23

    	 

    

 

	7.11.	PREFERENTIAL COLLECTION OF CLAIMS AGAINST COMPANY.

 

The Trustee shall comply
with TIA Section 311(a), excluding any creditor relationship listed in TIA Section 311(b). A Trustee who has resigned or been removed
shall be subject to TIA Section 311(a) to the extent indicated therein.

 

	7.12.	PAYING AGENTS.

 

The Company shall cause
each Paying Agent other than the Trustee to execute and deliver to it and the Trustee an instrument in which such agent shall agree with
the Trustee, subject to the provisions of this Section 7.12:

 

(1) that it will hold
all sums held by it as agent for the payment of the principal of, or interest or premium, if any, on, the Securities (whether such sums
have been paid to it by the Company or by any obligor on the Securities) in trust for the benefit of Holders of the Securities or the
Trustee;

 

(2) that it will at any
time during the continuance of any Event of Default, upon written request from the Trustee, deliver to the Trustee all sums so held in
trust by it together with a full accounting thereof; and

 

(3) that it will give
the Trustee written notice within three Business Days after any failure of the Company (or by any obligor on the Securities) in the payment
of any installment of the principal of, or interest or premium, if any, on, the Securities when the same shall be due and payable.

 

ARTICLE 8

 

AMENDMENTS, SUPPLEMENTS
AND WAIVERS

 

	8.1.	WITHOUT CONSENT OF HOLDERS.

 

The Company, when authorized
by a Board Resolution, and the Trustee may amend or supplement this Indenture or the Securities of one or more Series without notice to
or consent of any Securityholder:

 

(1) to comply with Section
5.1;

 

(2) to provide for certificated
Securities in addition to uncertificated Securities;

 

(3) to comply with any
requirements of the SEC under the TIA;

 

(4) to cure any ambiguity,
defect or inconsistency, or to make any other change herein or in the Securities that does not materially and adversely affect the rights
of any Securityholder;

 

(5) to provide for the
issuance of, and establish the form and terms and conditions of, Securities of any Series as permitted by this Indenture; or

 

(6) to evidence and provide
for the acceptance of appointment hereunder by a successor Trustee with respect to the Securities of one or more Series, and to add to
or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts
hereunder by more than one Trustee.

 

The Trustee is hereby
authorized to join with the Company in the execution of any supplemental indenture authorized or permitted by the terms of this Indenture,
and to make any further appropriate agreements and stipulations which may be therein contained, but the Trustee shall not be obligated
to enter into any such supplemental indenture which adversely affects its own rights, duties or immunities under this Indenture.

 

    24

    	 

    

 

	8.2.	WITH CONSENT OF HOLDERS.

 

(a) The Company, when
authorized by a Board Resolution, and the Trustee may amend or supplement this Indenture or the Securities of one or more Series with
the written consent of the Holders of not less than a majority in aggregate principal amount of the outstanding Securities of such Series
affected by such amendment or supplement without notice to any Securityholder. The Holders of not less than a majority in aggregate principal
amount of the outstanding Securities of each such Series affected by such amendment or supplement may waive compliance by the Company
in a particular instance with any provision of this Indenture or the Securities of such Series without notice to any Securityholder. Subject
to Section 8.4, without the consent of each Securityholder affected, however, an amendment, supplement or waiver may not:

 

(1) reduce the amount
of Securities whose Holders must consent to an amendment, supplement or waiver to this Indenture or the Securities;

 

(2) reduce the rate of,
or change the time for payment of, interest on any Security;

 

(3) reduce the principal,
or change the Stated Maturity, of any Security, or reduce the amount of, or postpone the date fixed for, the payment of any sinking fund
or analogous obligation;

 

(4) make any Security
payable in money other than that stated in the Security;

 

(5) change the amount
or time of any payment required by the Securities, or reduce the premium payable upon any redemption of the Securities, or change the
time before which no such redemption may be made;

 

(6) waive a Default or
Event of Default in the payment of the principal of, or interest or premium, if any, on, any Security (except a rescission of acceleration
of the Securities of any Series by the Holders of at least a majority in principal amount of the outstanding Securities of such Series
and a waiver of the payment default that resulted from such acceleration);

 

(7) waive a redemption
payment with respect to any Security, or change any of the provisions with respect to the redemption of any Securities;

 

(8) make any changes
in Section 6.6 or this Section 8.2, except to increase any percentage of Securities the Holders of which must consent to any matter;
or

 

(9) take any other action
otherwise prohibited by this Indenture to be taken without the consent of each Holder affected thereby.

 

(b) Upon the request
of the Company, accompanied by a Board Resolution authorizing the execution of any such supplemental indenture, and upon the receipt by
the Trustee of evidence reasonably satisfactory to the Trustee of the consent of the Securityholders as aforesaid and of the documents
described in Section 8.6, the Trustee shall join with the Company in the execution of such supplemental indenture, unless such supplemental
indenture affects the Trustee’s own rights, duties or immunities under this Indenture, in which case the Trustee may in its discretion,
but shall not be obligated to, enter into such supplemental indenture.

 

(c) It shall not be necessary
for the consent of the Holders under this section to approve the particular form of any proposed amendment, supplement or waiver, but
it shall be sufficient if such consent approves the substance thereof.

 

After an amendment or
supplement under this Section becomes effective, the Company shall mail to Securityholders a notice briefly describing the amendment or
supplement. Any failure of the Company to mail any such notice, or any defect therein, shall not, however, in any way impair or affect
the validity of any supplemental indenture.

 

    25

    	 

    

 

	8.3.	COMPLIANCE WITH TRUST INDENTURE ACT.

 

Every amendment to, or
supplement of, this Indenture or the Securities shall comply with the TIA as then in effect.

 

	8.4.	REVOCATION AND EFFECT OF CONSENTS.

 

Until an amendment, supplement,
waiver or other action becomes effective, a consent to it by a Holder of a Security is a continuing consent conclusive and binding upon
such Holder and every subsequent Holder of the same Security or portion thereof, and of any Security issued upon the transfer thereof
or in exchange therefor or in place thereof, even if notation of the consent is not made on any such Security. Any such Holder or subsequent
Holder, however, may revoke the consent as to his Security or portion of a Security, if the Trustee receives the notice of revocation
before the date the amendment, supplement, waiver or other action becomes effective.

 

The Company may, but
shall not be obligated to, fix a record date for the purpose of determining the Holders entitled to consent to any amendment, supplement
or waiver, which record date shall be at least 30 days prior to the first solicitation of such consent. If a record date is fixed, then,
notwithstanding the preceding paragraph, those Persons who were Holders at such record date (or their duly designated proxies), and only
such Persons, shall be entitled to consent to such amendment, supplement or waiver, or to revoke any consent previously given, whether
or not such Persons continue to be Holders after such record date.

 

After an amendment, supplement,
waiver or other action becomes effective, it shall bind every Securityholder, unless it makes a change described in any of clauses (1) through
(9) of Section 8.2. In that case, the amendment, supplement, waiver or other action shall bind each Holder of a Security who
has consented to it and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting
Holder’s Security; PROVIDED, that any such waiver shall not impair or affect the right of any Holder to receive payment of the principal
of, and interest and premium, if any, on, a Security, on or after the respective due dates expressed in such Security, or to bring suit
for the enforcement of any such payment on or after such respective dates without the consent of such Holder.

 

	8.5.	NOTATION ON OR EXCHANGE OF SECURITIES.

 

If an amendment, supplement
or waiver changes the terms of a Security of any Series, the Trustee may request the Holder of such Security to deliver it to the Trustee.
In such case, the Trustee shall place an appropriate notation on such Security about the changed terms and return it to the Holder. Alternatively,
the Company, in exchange for such Security, may issue, and the Trustee shall authenticate, a new security that reflects the changed terms.
Failure to make the appropriate notation or issue a new Security shall not affect the validity and effect of such amendment, supplement
or waiver.

 

	8.6.	TRUSTEE TO SIGN AMENDMENTS, ETC.

 

The Trustee shall sign
any amendment, supplement or waiver authorized pursuant to this Article 8 if the amendment, supplement or waiver does not adversely affect
the rights, duties, liabilities or immunities of the Trustee. If it does, the Trustee may, but need not, sign it. In signing or refusing
to sign such amendment, supplement or waiver the Trustee shall be entitled to receive and, subject to Section 7.1, shall be fully
protected in relying upon an Officers’ Certificate and an Opinion of Counsel stating that such amendment, supplement or waiver is
authorized or permitted by this Indenture. The Company may not sign an amendment or supplement until the Board of Directors of the Company
approves it.

 

    26

    	 

    

 

ARTICLE 9

 

DISCHARGE OF INDENTURE;
DEFEASANCE

 

	9.1.	DISCHARGE OF INDENTURE.

 

The Company may terminate
its obligations under the Securities of any Series and this Indenture with respect to such Series, except the obligations referred to
in the last paragraph of this Section 9.1, if there shall have been canceled by the Trustee, or delivered to the Trustee for cancellation,
all Securities of such Series theretofore authenticated and delivered (other than any Securities of such Series that are asserted to have
been destroyed, lost or stolen and that shall have been replaced as provided in Section 2.8) and the Company has paid all sums payable
by it hereunder or deposited all required sums with the Trustee.

 

After such delivery the
Trustee upon request shall acknowledge in a writing prepared by or on behalf of the Company the discharge of the Company’s obligations
under the Securities of such Series and this Indenture, except for those surviving obligations specified below.

 

Notwithstanding the satisfaction
and discharge of this Indenture, the obligations of the Company in Sections 7.7, 9.5 and 9.6 shall survive.

 

	9.2.	LEGAL DEFEASANCE.

 

The Company may at its
option, by Board Resolution, be discharged from its obligations with respect to the Securities of any Series on the date upon which the
conditions set forth in Section 9.4 below are satisfied (hereinafter, “Legal Defeasance”). For this purpose, such Legal Defeasance
means that the Company shall be deemed to have paid and discharged the entire indebtedness represented by the Securities of such Series
and to have satisfied all its other obligations under such Securities and this Indenture insofar as such Securities are concerned (and
the Trustee, at the expense of the Company, shall, subject to Section 9.6, execute proper instruments acknowledging the same, as are delivered
to it by the Company), except for the following, which shall survive until otherwise terminated or discharged hereunder: (A) the
rights of Holders of outstanding Securities of such Series to receive solely from the trust funds described in Section 9.4 and as more
fully set forth in such section, payments in respect of the principal of, and interest and premium, if any, on, the Securities of such
Series when such payments are due, (B) the Company’s obligations with respect to the Securities of such Series under Sections 2.4,
2.5, 2.6, 2.7, 2.8 and 2.9, (C) the rights, powers, trusts, duties and immunities of the Trustee hereunder (including claims of, or payments
to, the Trustee under or pursuant to Section 7.7) and (D) this Article 9. Subject to compliance with this Article 9, the Company may exercise
its option under this Section 9.2 with respect to the Securities of any Series notwithstanding the prior exercise of its option under
Section 9.3 below with respect to the Securities of such Series.

 

	9.3.	COVENANT DEFEASANCE.

 

At the option of the
Company, pursuant to a Board Resolution, the Company shall be released from its obligations with respect to the outstanding Securities
of any Series under Sections 4.2 through 4.5, inclusive, and Section 5.1, with respect to the outstanding Securities of such Series, on
and after the date the conditions set forth in Section 9.4 are satisfied (hereinafter, “Covenant Defeasance”). For this purpose,
such Covenant Defeasance means that the Company may omit to comply with and shall have no liability in respect of any term, condition
or limitation set forth in any such specified section or portion thereof, whether directly or indirectly by reason of any reference elsewhere
herein to any such specified Section or portion thereof or by reason of any reference in any such specified section or portion thereof
to any other provision herein or in any other document, but the remainder of this Indenture and the Securities of any Series shall be
unaffected thereby.

 

    27

    	 

    

 

	9.4.	CONDITIONS TO LEGAL DEFEASANCE OR COVENANT DEFEASANCE.

 

The following shall be
the conditions to application of Section 9.2 or Section 9.3 to the outstanding Securities of a Series:

 

(1) the Company shall
irrevocably have deposited or caused to be deposited with the Trustee (or another trustee satisfying the requirements of Section 7.10
who shall agree to comply with the provisions of this Article 9 applicable to it) as funds in trust for the purpose of making the following
payments, specifically pledged as security for, and dedicated solely to, the benefit of the Holders of the Securities, (A) money in an
amount, or (B) U.S. Government Obligations or Foreign Government Obligations which through the scheduled payment of principal and interest
in respect thereof in accordance with their terms will provide, not later than the due date of any payment, money in an amount, or (C)
a combination thereof, sufficient, in the opinion of a nationally recognized firm of independent public accountants expressed in a written
certification thereof delivered to the Trustee, to pay and discharge, and which shall be applied by the Trustee (or other qualifying trustee)
to pay and discharge, the principal of, and accrued interest and premium, if any, on, the outstanding Securities of such Series at the
Stated Maturity of such principal, interest or premium, if any, or on dates for payment and redemption of such principal, interest and
premium, if any, selected in accordance with the terms of this Indenture and of the Securities of such Series;

 

(2) no Event of Default
or Default with respect to the Securities of such Series shall have occurred and be continuing on the date of such deposit, or shall have
occurred and be continuing at any time during the period ending on the 91st day after the date of such deposit or, if longer, ending on
the day following the expiration of the longest preference period under any Bankruptcy Law applicable to the Company in respect of such
deposit as specified in the Opinion of Counsel identified in paragraph (8) below (it being understood that this condition shall not be
deemed satisfied until the expiration of such period);

 

(3) such Legal Defeasance
or Covenant Defeasance shall not cause the Trustee to have a conflicting interest for purposes of the TIA with respect to any securities
of the Company;

 

(4) such Legal Defeasance
or Covenant Defeasance shall not result in a breach or violation of, or constitute default under, any other agreement or instrument to
which the Company is a party or by which it is bound;

 

(5) the Company shall
have delivered to the Trustee an Opinion of Counsel stating that, as a result of such Legal Defeasance or Covenant Defeasance, neither
the trust nor the Trustee will be required to register as an investment company under the Investment Company Act of 1940, as amended;

 

(6) in the case of an
election under Section 9.2, the Company shall have delivered to the Trustee an Opinion of Counsel stating that (i) the Company has
received from, or there has been published by, the Internal Revenue Service a ruling to the effect that or (ii) there has been a change
in any applicable Federal income tax law with the effect that, and such opinion shall confirm that, the Holders of the outstanding Securities
of such Series or Persons in their positions will not recognize income, gain or loss for Federal income tax purposes solely as a result
of such Legal Defeasance and will be subject to Federal income tax on the same amounts, in the same manner, including as a result of prepayment,
and at the same times as would have been the case if such Legal Defeasance had not occurred;

 

(7) in the case of an
election under Section 9.3, the Company shall have delivered to the Trustee an Opinion of Counsel to the effect that the Holders of the
outstanding Securities of such Series will not recognize income, gain or loss for Federal income tax purposes as a result of such Covenant
Defeasance, and will be subject to Federal income tax on the same amounts, in the same manner and at the same times as would have been
the case if such Covenant Defeasance had not occurred;

 

(8) the Company shall
have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent provided
for in this Article 9 relating to either the Legal Defeasance under Section 9.2 or the Covenant Defeasance under Section 9.3 (as the case
may be) have been complied with;

 

(9) the Company shall
have delivered to the Trustee an Officers’ Certificate stating that the deposit under clause (1) was not made by the Company with
the intent of defeating, hindering, delaying or defrauding any creditors of the Company or others; and

 

    28

    	 

    

 

(10) the Company shall
have paid, or duly provided for payment under terms mutually satisfactory to the Company and the Trustee, all amounts then due to the
Trustee pursuant to Section 7.7.

 

	9.5.	DEPOSITED MONEY AND U.S. AND FOREIGN GOVERNMENT OBLIGATIONS TO BE HELD IN TRUST; OTHER MISCELLANEOUS PROVISIONS.

 

All money, U.S. Government
Obligations and Foreign Government Obligations (including the proceeds thereof) deposited with the Trustee pursuant to Section 9.4 in
respect of the outstanding Securities shall be held in trust and applied by the Trustee, in accordance with the provisions of such Securities
and this Indenture, to the payment, either directly or through any Paying Agent as the Trustee may determine, to the Holders of such Securities,
of all sums due and to become due thereon in respect of principal, accrued interest and premium, if any, but such money need not be segregated
from other funds except to the extent required by law.

 

The Company shall pay
and indemnify the Trustee against any tax, fee or other charge imposed on or assessed against the U.S. Government Obligations and Foreign
Government Obligations deposited pursuant to Section 9.4 or the principal, interest and premium, if any, received in respect thereof other
than any such tax, fee or other charge which by law is for the account of the Holders of the outstanding Securities.

 

Anything in this Article
9 to the contrary notwithstanding, but subject to payment of any of its outstanding fees and expenses, the Trustee shall deliver or pay
to the Company from time to time upon Company Request any money, U.S. Government Obligations or Foreign Government Obligations held by
the Trustee as provided in Section 9.4 which, in the opinion of a nationally-recognized firm of independent public accountants expressed
in a written certification thereof delivered to the Trustee, are in excess of the amount thereof which would then be required to be deposited
to effect an equivalent Legal Defeasance or Covenant Defeasance.

 

	9.6.	REINSTATEMENT.

 

If the Trustee or Paying
Agent is unable to apply any money, U.S. Government Obligations or Foreign Government Obligations in accordance with Section 9.1, 9.2,
9.3 or 9.4 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining
or otherwise prohibiting such application, the Company’s obligations under this Indenture and the Securities shall be revived and
reinstated as though no deposit had occurred pursuant to this Article 9 until such time as the Trustee or Paying Agent is permitted to
apply all such money, U.S. Government Obligations or Foreign Government Obligations, as the case may be, in accordance with Section 9.1,
9.2, 9.3 or 9.4; PROVIDED, HOWEVER, that if the Company has made any payment of principal of, or accrued interest or premium, if any,
on, any Securities because of the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such
Securities to receive such payment from the money, U.S. Government Obligations or Foreign Government Obligations held by the Trustee or
Paying Agent.

 

	9.7.	MONEYS HELD BY PAYING AGENT.

 

In connection with the
satisfaction and discharge of this Indenture, all moneys then held by any Paying Agent under the provisions of this Indenture shall, upon
demand of the Company, be paid to the Trustee, or, if sufficient moneys have been deposited pursuant to Section 9.1, to the Company, and
thereupon such Paying Agent shall be released from all further liability with respect to such moneys.

 

    29

    	 

    

 

	9.8.	MONEYS HELD BY TRUSTEE.

 

Any moneys deposited
with the Trustee or any Paying Agent or then held by the Company in trust for the payment of the principal of, or interest or premium,
if any, on, any Security that are not applied but remain unclaimed by the Holder of such Security for two years after the date upon which
the principal of, or interest or premium, if any, on, such Security shall have respectively become due and payable shall be repaid to
the Company upon Company Request, or if such moneys are then held by the Company in trust, such moneys shall be released from such trust;
and the Holder of such Security entitled to receive such payment shall thereafter, as an unsecured general creditor, look only to the
Company for the payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust money shall thereupon
cease; PROVIDED, HOWEVER, that the Trustee or any such Paying Agent, before being required to make any such repayment, may, at the expense
of the Company, either mail to each Securityholder affected, at the address shown in the register of the Securities maintained by the
Registrar, or cause to be published once a week for two successive weeks, in a newspaper published in the English language, customarily
published each Business Day and of general circulation in the City of New York, New York, a notice that such money remains unclaimed and
that, after a date specified therein, which shall not be less than 30 days from the date of such mailing or publication, any unclaimed
balance of such moneys then remaining will be repaid to the Company. After payment to the Company or the release of any money held in
trust by the Company, Securityholders entitled to the money must look only to the Company for payment as general creditors, unless applicable
abandoned property law designates another Person.

 

ARTICLE 10

 

MISCELLANEOUS

 

	10.1.	TRUST INDENTURE ACT CONTROLS.

 

If any provision of this
Indenture limits, qualifies or conflicts with another provision which is required to be included in this Indenture by the TIA, the required
provision shall control. If any provision of this Indenture modifies or excludes any provision of the TIA which may be so modified or
excluded, the latter provision shall be deemed to apply to this Indenture as so modified or to be excluded, as the case may be.

 

	10.2.	NOTICES.

 

Any notice or communication
shall be given in writing and delivered in Person, sent by facsimile (and receipt confirmed by telephone or electronic transmission report),
delivered by commercial courier service or mailed by first-class mail, postage prepaid, addressed as follows:

 

If to the Company:

 

	 	Citius Pharmaceuticals, Inc.
	 	11 Commerce Drive, First Floor
	 	Cranford, New Jersey 07016
	 	Attention:  Chief Executive Officer

 

Copy to:

 

	 	Wyrick Robbins Yates & Ponton LLP
	 	4101 Lake Boone Trail, Suite 300
	 	Raleigh, NC 27607
	 	Fax: (919) 781-4000
	 	Attention: Alexander M. Donaldson, Esq.

 

If to the Trustee:

 

	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 

 

The Company or the Trustee
by written notice to the other may designate additional or different addresses for subsequent notices or communications. Any notice or
communication to the Company or the Trustee shall be deemed to have been given or made as of the date so delivered if personally delivered;
when receipt is confirmed by telephone or electronic transmission report, if sent by facsimile; and three Business Days after mailing
if sent by registered or certified mail, postage prepaid (except that a notice of change of address shall not be deemed to have been given
until actually received by the addressee).

 

    30

    	 

    

 

Any notice or communication
mailed to a Securityholder shall be mailed to such Securityholder by first-class mail, postage prepaid, at such Securityholder’s
address shown on the register kept by the Registrar.

 

Failure to mail, or any
defect in, a notice or communication to a Securityholder shall not affect its sufficiency with respect to other Securityholders. If a
notice or communication to a Securityholder is mailed in the manner provided above, it shall be deemed duly given, three Business Days
after such mailing, whether or not the addressee receives it.

 

In case by reason of
the suspension of regular mail service, or by reason of any other cause, it shall be impossible to mail any notice as required by this
Indenture, then such method of notification as shall be made with the approval of the Trustee shall constitute a sufficient mailing of
such notice.

 

In the case of Global
Securities, notices or communications to be given to Securityholders shall be given to the Depository, in accordance with its applicable
policies as in effect from time to time.

 

In addition to the manner
provided for in the foregoing provisions, notices or communications to Securityholders shall be given by the Company by release made to
Reuters Economic Services and Bloomberg Business News.

 

	10.3.	COMMUNICATIONS BY HOLDERS WITH OTHER HOLDERS.

 

Securityholders of any
Series may communicate pursuant to TIA Section 312(b) with other Securityholders of that Series or any other Series with respect to their
rights under this Indenture or the Securities of that Series or any other Series. The Company, the Trustee, the Registrar and any other
Person shall have the protection of TIA Section 312(c).

 

	10.4.	CERTIFICATE AND OPINION AS TO CONDITIONS PRECEDENT.

 

Upon any request or application
by the Company to the Trustee to take any action under this Indenture, the Company shall furnish to the Trustee:

 

(1) an Officers’
Certificate (which shall include the statements set forth in Section 10.5 below) stating that, in the opinion of the signers, all conditions
precedent, if any, provided for in this Indenture relating to the proposed action have been complied with; and

 

(2) an Opinion of Counsel
(which shall include the statements set forth in Section 10.5 below) stating that, in the opinion of such counsel, all such conditions
precedent have been complied with.

 

	10.5.	STATEMENT REQUIRED IN CERTIFICATE AND OPINION.

 

Each certificate and
opinion with respect to compliance with a condition or covenant provided for in this Indenture (other than pursuant to Section 4.4)
shall include:

 

(1) a statement that
the Person making such certificate or opinion has read such covenant or condition;

 

(2) a brief statement
as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or
opinion are based;

 

(3) a statement that,
in the opinion of such Person, it or he has made such examination or investigation as is necessary to enable it or him to express an informed
opinion as to whether or not such covenant or condition has been complied with; and

 

(4) a statement as to
whether or not, in the opinion of such Person, such covenant or condition has been complied with.

 

    31

    	 

    

 

	10.6.	RULES BY TRUSTEE AND AGENTS.

 

The Trustee may make
reasonable rules for action by or at meetings of Securityholders. The Registrar and Paying Agent may make reasonable rules for their functions.

 

	10.7.	BUSINESS DAYS; LEGAL HOLIDAYS; PLACE OF PAYMENT.

 

A “Business Day”
is a day that is not a Legal Holiday. A “Legal Holiday” is a Saturday, a Sunday, a federally-recognized holiday or a day on
which banking institutions are not authorized or required by law, regulation or executive order to be open in the State of New York.

 

If a payment date is
a Legal Holiday at a Place of Payment, payment may be made at that place on the next succeeding day that is not a Legal Holiday, and no
interest shall accrue for the intervening period. “Place of Payment” means the place or places where the principal of, and
interest and premium, if any, on, the Securities of a Series are payable as specified as contemplated by Section 2.2. If the regular record
date is a Legal Holiday, the record date shall not be affected.

 

	10.8.	GOVERNING LAW.

 

THIS INDENTURE AND
THE SECURITIES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, AS APPLIED TO CONTRACTS MADE AND
PERFORMED WITHIN THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW.

 

	10.9.	NO ADVERSE INTERPRETATION OF OTHER AGREEMENTS.

 

This Indenture may not
be used to interpret another indenture, loan, security or debt agreement of the Company or any Subsidiary thereof. No such indenture,
loan, security or debt agreement may be used to interpret this Indenture.

 

	10.10.	NO RECOURSE AGAINST OTHERS.

 

A director, officer,
employee, stockholder or incorporator, as such, of the Company shall not have any liability for any obligations of the Company under the
Securities or the Indenture. Each Securityholder by accepting a Security waives and releases all such liability. Such waiver and release
are part of the consideration for the issuance of the Securities.

 

	10.11.	SUCCESSORS.

 

All covenants and agreements
of the Company in this Indenture and the Securities shall bind the Company’s successors and assigns, whether so expressed or not.
All agreements of the Trustee, any additional trustee and any Paying Agents in this Indenture shall bind their respective successors and
assigns.

 

	10.12.	MULTIPLE COUNTERPARTS.

 

The parties may sign
multiple counterparts of this Indenture. Each signed counterpart shall be deemed an original, but all of them together represent one and
the same agreement.

 

	10.13.	TABLE OF CONTENTS, HEADINGS, ETC.

 

The table of contents,
cross-reference sheet and headings of the Articles and Sections of this Indenture have been inserted for convenience of reference only,
are not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof.

 

    32

    	 

    

 

	10.14.	SEVERABILITY.

 

Each provision of this
Indenture shall be considered separable, and if for any reason any provision which is not essential to the effectuation of the basic purpose
of this Indenture or the Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining
provisions shall not in any way be affected or impaired thereby, and a Holder shall have no claim therefor against any party hereto.

 

	10.15.	SECURITIES IN A FOREIGN CURRENCY OR IN EUROS.

 

Unless otherwise specified
in a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate delivered pursuant to Section 2.2 with respect
to a particular Series of Securities, whenever for purposes of this Indenture any action may be taken by the Holders of a specified percentage
in aggregate principal amount of Securities of all Series or all Series affected by a particular action at the time outstanding and, at
such time, there are outstanding Securities of any Series which are denominated in a coin or currency other than Dollars (including Euros),
then the principal amount of Securities of such Series which shall be deemed to be outstanding for the purpose of taking such action shall
be that amount of Dollars that could be obtained for such amount at the Market Exchange Rate at such time. For purposes of this Section
10.15, “Market Exchange Rate” shall mean the noon Dollar buying rate in New York City for cable transfers of that currency
as published by the Federal Reserve Bank of New York; PROVIDED, HOWEVER, in the case of Euros, Market Exchange Rate shall mean the rate
of exchange determined by the Commission of the European Union (or any successor thereto) as published in the Official Journal of the
European Union (such publication or any successor publication, the “Journal”). If such Market Exchange Rate is not available
for any reason with respect to such currency, the Trustee shall use, in its sole discretion and without liability on its part, such quotation
of the Federal Reserve Bank of New York or, in the case of Euros, the rate of exchange as published in the Journal, as of the most recent
available date, or quotations or, in the case of Euros, rates of exchange from one or more major banks in New York City or in the country
of issue of the currency in question or, in the case of Euros, in Luxembourg or such other quotations or, in the case of Euros, rates
of exchange as the Trustee, upon consultation with the Company, shall deem appropriate. The provisions of this paragraph shall apply in
determining the equivalent principal amount in respect of Securities of a Series denominated in currency other than Dollars in connection
with any action taken by Holders of Securities pursuant to the terms of this Indenture.

 

All decisions and determinations
of the Trustee regarding the Market Exchange Rate or any alternative determination provided for in the preceding paragraph shall be in
the Trustee’s sole discretion, and shall, in the absence of manifest error, be conclusive to the extent permitted by law for all
purposes and irrevocably binding upon the Company and all Holders.

 

	10.16.	JUDGMENT CURRENCY.

 

The Company agrees, to
the fullest extent that it may effectively do so under applicable law, that (a) if for the purpose of obtaining judgment in any court
it is necessary to convert the sum due in respect of the principal of, or interest or premium, if any, or other amount on, the Securities
of any Series (the “Required Currency”) into a currency in which a judgment will be rendered (the “Judgment Currency”),
the rate of exchange used shall be the rate at which, in accordance with normal banking procedures, the Trustee could purchase in The
City of New York the Required Currency with the Judgment Currency on the day on which final unappealable judgment is entered, unless such
day is not a Business Day, in which instance, the rate of exchange used shall be the rate at which, in accordance with normal banking
procedures, the Trustee could purchase in The City of New York the Required Currency with the Judgment Currency on the Business Day preceding
the day on which final unappealable judgment is entered and (b) its obligations under this Indenture to make payments in the Required
Currency (i) shall not be discharged or satisfied by any tender or any recovery pursuant to any judgment (whether or not entered
in accordance with subsection (a)) in any currency other than the Required Currency, except to the extent that such tender or recovery
shall result in the actual receipt, by the payee, of the full amount of the Required Currency expressed to be payable in respect of such
payments, (ii) shall be enforceable as an alternative or additional cause of action for the purpose of recovering in the Required
Currency the amount, if any, by which such actual receipt shall fall short of the full amount of the Required Currency so expressed to
be payable and (iii) shall not be affected by judgment being obtained for any other sum due under this Indenture.

 

    33

    	 

    

 

IN WITNESS WHEREOF, the
parties hereto have caused this Indenture to be duly executed, and their respective corporate seals to be hereunto affixed and attested,
all as of the day and year first above written.

 

	 	CITIUS PHARMACEUTICALS, INC.
	 	 	 
	 	By:	
                                          
	 	Name:	

	 	Title:	

	 	 
	 	[Name of Trustee]
	 	 	 
	 	By:	

	 	Name:	

	 	Title:	

	 	 	 
	 	By:	

	 	Name:	

	 	Title:	

 

 

34Exhibit 10.1

 

INVESTOR RIGHTS AGREEMENT

 

BY AND AMONG

 

DIVERSEY HOLDINGS, LTD.

 

AND

 

CERTAIN SHAREHOLDERS

 

DATED AS OF March
29, 2021

 

     

     

    

 

Table
of Contents

 

Page

 

	Article I EFFECTIVENESS 	1
	 	 	 
	Section 1.1	Effectiveness	1
	 	 	 
	Article II DEFINITIONS 	1
	 	 	 
	Section 2.1	Definitions	1
	 	 	 
	Section 2.2	Other Interpretive Provisions	5
	 	 	 
	Article III REGISTRATION RIGHTS 	6
	 	 	 
	Section 3.1	Demand Registration	6
	 	 	 
	Section 3.2	Shelf Registration	8
	 	 	 
	Section 3.3	Piggyback Registration	11
	 	 	 
	Section 3.4	Lock-Up Agreements	12
	 	 	 
	Section 3.5	Registration Procedures	13
	 	 	 
	Section 3.6	Underwritten Offerings	18
	 	 	 
	Section 3.7	No Inconsistent Agreements; Additional Rights	19
	 	 	 
	Section 3.8	Registration Expenses	20
	 	 	 
	Section 3.9	Indemnification	21
	 	 	 
	Section 3.10	Rules 144 and 144A and Regulation S	24
	 	 	 
	Article IV GOVERNANCE 	24
	 	 	 
	Section 4.1	Board Nomination Rights	24
	 	 	 
	Section 4.2	Board Committees	26
	 	 	 
	Section 4.3	Expenses; D&O Insurance	26
	 	 	 
	Section 4.4	Written Consent or Resolutions	26
	 	 	 
	Section 4.5	Remedies	26
	 	 	 
	Section 4.6	Company Obligations	27

 

    	 	i	 

     

    

 

Table of Contents (cont’d)

 

Page

 

	Article V MISCELLANEOUS 	27
	 	 	 
	Section 5.1	Authority; Effect	27
	 	 	 
	Section 5.2	Notices	27
	 	 	 
	Section 5.3	Termination and Effect of Termination	28
	 	 	 
	Section 5.4	Permitted Transferees	29
	 	 	 
	Section 5.5	Remedies	29
	 	 	 
	Section 5.6	Amendments	29
	 	 	 
	Section 5.7	Governing Law	29
	 	 	 
	Section 5.8	Consent to Jurisdiction	30
	 	 	 
	Section 5.9	WAIVER OF JURY TRIAL	30
	 	 	 
	Section 5.10	Merger; Binding Effect, Etc	30
	 	 	 
	Section 5.11	Counterparts; Electronic Signature	30
	 	 	 
	Section 5.12	Severability	31
	 	 	 
	Section 5.13	No Recourse	31

 

 

    	 	ii	 

     

    

 

This INVESTOR RIGHTS AGREEMENT
(as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as of March 29,
2021 is made by and among:

 

		(a)	Diversey Holdings, Ltd., a company organized under the laws of the Cayman Islands (the “Company”);

 

		(b)	each of the entities affiliated with Bain Capital Fund XI, L.P., a Cayman Islands Exempted Limited Partnership,
listed on the signature pages hereto under the caption “Bain Capital” (together with any Permitted Transferee, “Bain
Capital”); and

 

		(c)	each of the shareholders of the Company listed on the signature pages hereto under the caption “Investors”
(collectively with Bain Capital, the “Investors”).

 

RECITALS

 

WHEREAS, the Company is contemplating
an underwritten initial public offering of its ordinary shares pursuant to an effective registration statement filed with the Securities
and Exchange Commission on Form S-1 in the United States (the “IPO”); and

 

WHEREAS, the parties believe
that it is in the best interests of the Company and the other parties hereto to set forth their agreements regarding rights as investors
in the Company.

 

NOW, THEREFORE, in consideration
of the foregoing and the mutual promises, covenants and agreements of the parties hereto, and for other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

 

Article I

EFFECTIVENESS

 

Section 1.1         Effectiveness.
This Agreement shall become effective as of the date hereof.

 

Article II

DEFINITIONS

 

Section 2.1         Definitions.
As used in this Agreement, the following terms shall have the following meanings:

 

“Adverse Disclosure”
means public disclosure of material non-public information that, in the good faith judgment of the Board: (i) would be required to
be made in any Registration Statement filed with the SEC by the Company so that such Registration Statement, from and after its effective
date, does not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
to make the statements therein not misleading; (ii) would not be required to be made at such time but for the filing, effectiveness
or continued use of such Registration Statement; and (iii) the Company has a bona fide business purpose for not disclosing
publicly.

 

    	 	 1	 

     

    

 

“Affiliate”
means, with respect to any specified Person, (a) any Person that directly or indirectly through one or more intermediaries controls,
or is controlled by, or is under common control with, such specified Person or (b) in the event that the specified Person is a natural
Person, the spouse and descendants of such Person; provided that the Company and each of its subsidiaries shall be deemed not to
be Affiliates of any Holder. As used in this definition, the term “control” means the possession, directly or indirectly,
of the power to direct or cause the direction of the management and policies of a Person, whether through ownership of voting securities,
by contract or otherwise.

 

“Agreement”
shall have the meaning set forth in the preamble.

 

“Articles”
means the memorandum and articles of association of the Company, as they will be in effect upon completion of the IPO, as amended from
time to time.

 

“Bain Director”
means a Director that has been designated by Bain Capital for election as Nominee or appointment pursuant to Section 4.1.

 

“Board”
means the board of directors of the Company.

 

“Business Day”
means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by law to be closed in the City
of New York.

 

“Charitable Gifting
Event” means any Transfer by a holder of Registrable Securities, or any subsequent Transfer by such Holder’s members,
partners or other employees, in connection with a bona fide gift to any Charitable Organization made on the date of, but prior to, the
execution of the underwriting agreement entered into in connection with any Underwritten Public Offering.

 

“Charitable Organization”
means a charitable organization as described by Section 501(c)(3) of the U.S. Internal Revenue Code of 1986, as in effect from
time to time.

 

“Company Indemnitee”
shall have the meaning set forth in Section 3.9.5.

 

“Demand Notice”
shall have the meaning set forth in Section 3.1.3.

 

“Demand Registration”
shall have the meaning set forth in Section 3.1.1(a).

 

“Demand Registration
Request” shall have the meaning set forth in Section 3.1.1(a).

 

“Demand Registration
Statement” shall have the meaning set forth in Section 3.1.1(c).

 

“Demand Suspension”
shall have the meaning set forth in Section 3.1.6.

 

“Director”
means a director on the Board.

 

“Director Election
Meeting” means any general meeting at which Directors are to be elected to the Board.

 

    	 	 2	 

     

    

 

“Exchange Act”
means the Securities Exchange Act of 1934, as amended, and any successor thereto, and any rules and regulations promulgated thereunder,
all as the same shall be in effect from time to time.

 

“FINRA”
means the Financial Industry Regulatory Authority.

 

“Holder”
means an Investor that holds Registrable Securities.

 

“Independent Director”
means an independent Director, as determined by the Nominating and Governance Committee in accordance with the rules promulgated
by Nasdaq and applicable law.

 

“Investor”
shall have the meaning set forth in the preamble.

 

“Issuer Free Writing
Prospectus” means an issuer free writing prospectus, as defined in Rule 433 under the Securities Act, relating to an offer
of the Registrable Securities.

 

“Loss”
shall have the meaning set forth in Section 3.9.1.

 

“Nominating and Governance
Committee” shall mean the Nominating and Governance Committee of the Board, or any similar committee of the Board.

 

“Nominee”
means a nominee proposed for election as Director by the Company and included as a nominee in the proxy statement of the Company relating
to a Director Election Meeting.

 

“Nasdaq”
means the Nasdaq Capital Market, LLC.

 

“Participation Conditions”
shall have the meaning set forth in Section 3.2.5(b).

 

“Permitted Transferee”
means any Affiliate of an Investor.

 

“Person”
means any individual, partnership, corporation, company, association, trust, joint venture, limited liability company, unincorporated
organization, entity or division, or any government, governmental department or agency or political subdivision thereof.

 

“Piggyback Notice”
shall have the meaning set forth in Section 3.3.1.

 

“Piggyback Registration”
shall have the meaning set forth in Section 3.3.1.

 

“Potential Takedown
Participant” shall have the meaning set forth in Section 3.2.5(b).

 

“Pro Rata Portion”
means, with respect to each Holder requesting that its shares be registered or sold in an Underwritten Public Offering, a number of such
shares equal to the aggregate number of Registrable Securities to be registered or sold (excluding any shares to be registered or sold
for the account of the Company) multiplied by a fraction, the numerator of which is the aggregate number of Registrable Securities held
by such Holder, and the denominator of which is the aggregate number of Registrable Securities held by all Holders requesting that their
Registrable Securities be registered or sold.

 

    	 	 3	 

     

    

 

“Prospectus”
means (i) the prospectus included in any Registration Statement, all amendments and supplements to such prospectus, including post-effective
amendments and supplements, and all other material incorporated by reference in such prospectus, and (ii) any Issuer Free Writing
Prospectus.

 

“Public Offering”
means the offer and sale of Registrable Securities for cash pursuant to (i) an effective Registration Statement under the Securities
Act (other than a Registration Statement on Form S-4 or Form S-8 or any successor form), or (ii) comparable mechanics under
the securities laws of any other jurisdiction.

 

“Registrable Securities”
means (i) all Ordinary Shares held by the Investors that are not then subject to forfeiture to the Company and (ii) all Ordinary
Shares directly or indirectly issued or then issuable by way of a stock dividend or stock split, or in connection with a combination of
shares, recapitalization, merger, consolidation or other reorganization. As to any particular Registrable Securities, such securities
shall cease to be Registrable Securities when (w) a Registration Statement with respect to the sale of such securities shall have
become effective under the Securities Act and such securities shall have been disposed of in accordance with such Registration Statement,
(x) such securities shall have been Transferred pursuant to Rule 144, (y) such Holder is able to immediately sell such
securities under Rule 144 without any restrictions on transfer (including without application of paragraphs (c), (d), (e), (f) and
(h) of Rule 144), or (z) such securities shall have ceased to be outstanding.

 

“Registration”
means a (i) registration under the Securities Act of the offer and sale to the public of any Registrable Securities under a Registration
Statement, or (ii) comparable mechanics under the securities laws of any other jurisdiction. The terms “register”,
 “registered” and “registering” shall have correlative meanings.

 

“Registration Expenses”
shall have the meaning set forth in Section 3.8.

 

“Registration Statement”
means any registration statement of the Company filed with, or to be filed with, the SEC under the Securities Act, including the related
Prospectus, amendments and supplements to such registration statement, including pre- and post-effective amendments, and all exhibits
and all material incorporated by reference in such registration statement other than a registration statement (and related Prospectus)
filed on Form S-4 or Form S-8 or any successor form thereto.

 

“Representatives”
means, with respect to any Person, any of such Person’s officers, directors, employees, agents, attorneys, accountants, actuaries,
consultants, equity financing partners or financial advisors or other Person associated with, or acting on behalf of, such Person.

 

“Rule 144”
means Rule 144 under the Securities Act (or any successor rule).

 

“SEC” means
the Securities and Exchange Commission or any successor agency having jurisdiction under the Securities Act.

 

“Securities Act”
means the Securities Act of 1933, as amended, and any successor thereto, and any rules and regulations promulgated thereunder, all
as the same shall be in effect from time to time.

 

    	 	 4	 

     

    

 

“Shelf Period”
shall have the meaning set forth in Section 3.2.3.

 

“Shelf Registration”
shall have the meaning set forth in Section 3.2.1(a).

 

“Shelf Registration
Notice” shall have the meaning set forth in Section 3.2.2.

 

“Shelf Registration
Request” shall have the meaning set forth in Section 3.2.1(a).

 

“Shelf Registration
Statement” shall have the meaning set forth in Section 3.2.1(a).

 

“Shelf Suspension”
shall have the meaning set forth in Section 3.2.4.

 

“Shelf Takedown Notice”
shall have the meaning set forth in Section 3.2.5(b).

 

“Shelf Takedown Request”
shall have the meaning set forth in Section 3.2.5(a).

 

“Transfer”
means, with respect to any Registrable Security, any interest therein, or any other securities or equity interests relating thereto, a
direct or indirect transfer, sale, exchange, assignment, pledge, hypothecation or other encumbrance or other disposition thereof, including
the grant of an option or other right, whether directly or indirectly, whether voluntarily, involuntarily, by operation of law, pursuant
to judicial process or otherwise. “Transferred” shall have a correlative meaning.

 

“Underwritten Public
Offering” means an underwritten Public Offering, including any bought deal or block sale to a financial institution conducted
as an underwritten Public Offering.

 

“Underwritten Shelf
Takedown” means an Underwritten Public Offering pursuant to an effective Shelf Registration Statement.

 

“WKSI”
means any Securities Act registrant that is a well-known seasoned issuer as defined in Rule 405 under the Securities Act at the most
recent eligibility determination date specified in paragraph (2) of that definition.

 

Section 2.2         Other
Interpretive Provisions.

 

		(a)	The meanings of defined terms are equally applicable to the singular and plural forms of the defined terms.

 

		(b)	The words “hereof”, “herein”, “hereunder” and similar words refer
to this Agreement as a whole and not to any particular provision of this Agreement; and any subsection and section references are to this
Agreement unless otherwise specified.

 

		(c)	The term “including” is not limiting and means “including without limitation.”

 

		(d)	The captions and headings of this Agreement are for convenience of reference only and shall not affect
the interpretation of this Agreement.

 

		(e)	Whenever the context requires, any pronouns used herein shall include the corresponding masculine, feminine
or neuter forms.

 

    	 	 5	 

     

    

 

Article III

REGISTRATION RIGHTS

 

The Company will perform and
comply, and cause each of its subsidiaries to perform and comply, with such of the following provisions as are applicable to it. Each
Holder will perform and comply with such of the following provisions as are applicable to such Holder.

 

Section 3.1         Demand
Registration.

 

Section 3.1.1      Request
for Demand Registration.

 

		(a)	At any time following the date of this Agreement, Bain Capital shall have the right to make a written
request from time to time (a “Demand Registration Request”) to the Company for Registration of all or any portion of
the Registrable Securities held by such Holder on Form S-1 or any similar long-form registration statement (“Long-Form Registrations”)
or on Form S-3 or any similar short-form registration statement (“Short-Form Registrations”), if available
(any such requested registration, a “Demand Registration”). All Long-Form Registrations will be underwritten registrations
unless otherwise approved by Bain Capital. Demand Registrations will be Short-Form Registrations whenever the Company is permitted
to use any applicable short form and if the managing underwriters (if any) and Bain Capital agrees to the use of a Short-Form Registration.

 

		(b)	Each Demand Registration Request shall specify (x) the approximate amount of such Holder’s
Registrable Securities to be registered and (y) if known, the intended method or methods of disposition thereof. Bain Capital will
be entitled to request an unlimited number of Demand Registrations in which the Company will pay all Registration Expenses, whether or
not any such registration is consummated.

 

		(c)	Upon receipt of a Demand Registration Request, the Company shall as promptly as practicable (and in any
event within forty-give (45) days, in the case of a Long-Form Registration, or fifteen (15) days, in the case of a Short-Form Registration)
file a Registration Statement (a “Demand Registration Statement”) relating to such Demand Registration, and use its
best efforts to cause such Demand Registration Statement to be promptly declared effective under the Securities Act.

 

Section 3.1.2      Demand
Notice. Within five (5) days after receipt of any such request, the Company will give written notice of the Demand Registration
to all other Holders and subject to the terms of Section 3.1.7, will include in such Demand Registration (and in all related
registrations and qualifications under state blue sky laws and in any related underwriting) all Registrable Securities with respect to
which the Company has received written requests for inclusion therein within five (5) days after the receipt of the Company’s
notice; provided that, with the consent of Bain Capital, the Company may instead provide notice of the Demand Registration
to all other Holders within three (3) Business Days following the non-confidential filing of the registration statement with respect
to the Demand Registration so long as such registration statement is not an automatic shelf registration statement (as defined in Rule 405
under the Securities Act).

 

Section 3.1.3      Demand
Withdrawal. The Holders may withdraw all or any portion of their Registrable Securities included in a Demand Registration from such
Demand Registration at any time prior to the effectiveness of the Demand Registration Statement or the filing of the Demand, as applicable.
Upon receipt of a notice to such effect from Bain Capital, the Company shall cease all efforts to pursue or consummate such Demand Registration.

 

    	 	 6	 

     

    

 

Section 3.1.4      Effective
Registration. The Company shall use reasonable best efforts to cause any Demand Registration Statement to become effective and remain
effective for not less than one hundred eighty (180) days (or such shorter period as will terminate when all Registrable Securities covered
by such Demand Registration Statement have been sold or withdrawn), or, if such Demand Registration Statement relates to an Underwritten
Public Offering, such longer period as in the opinion of counsel for the underwriter or underwriters a Prospectus is required by law
to be delivered in connection with sales of Registrable Securities by an underwriter or dealer.

 

Section 3.1.5      Delay
in Filing; Suspension of Registration. If the filing, initial effectiveness or continued use of a Demand Registration Statement at
any time would require the Company to make an Adverse Disclosure, the Company may, upon giving prompt written notice of such action to
the Holders, delay the filing or initial effectiveness of, or suspend use of, as applicable, the Demand Registration Statement (a “Demand
Suspension”); provided, however, that the Company shall not be permitted to exercise a Demand Suspension more
than once during any twelve (12)-month period and such Demand Suspension may not exceed sixty (60) days. In the case of a Demand Suspension,
the Holders agree to suspend use of any applicable Prospectus in connection with any sale or purchase, or offer to sell or purchase,
Registrable Securities, upon receipt of the notice referred to above. The Company shall immediately notify the Holders in writing upon
the termination of any Demand Suspension, amend or supplement any Prospectus, if necessary, so it does not contain any untrue statement
or omission of a material fact, and furnish to the Holders such numbers of copies of any Prospectus as so amended or supplemented as
the Holders may reasonably request. The Company shall, if necessary, supplement or amend any Demand Registration Statement, if required
by the registration form used by the Company for the Demand Registration or by the instructions applicable to such registration form
or by the Securities Act or the rules or regulations promulgated thereunder or as may reasonably be requested by the Holders whose
Registrable Securities are included in such Demand Registration Statement.

 

Section 3.1.6      Priority
of Securities Registered Pursuant to Demand Registrations. If the managing underwriter or underwriters of a proposed Underwritten
Public Offering of the Registrable Securities included in a Demand Registration advise the Company in writing that, in its or their opinion,
the number of securities requested to be included in such Demand Registration exceeds the number that can be sold in such offering without
being likely to have an adverse effect on the price, timing or distribution of the securities offered or the market for the securities
offered, then the securities to be included in such Registration shall be allocated to the Holders based on each such Holder’s
Pro Rata Portion of the number of Registrable Securities that, in the opinion of such managing underwriter or underwriters, can be sold
without having such adverse effect.

 

    	 	 7	 

     

    

 

Section 3.2         Shelf
Registration.

 

Section 3.2.1      Request
for Shelf Registration.

 

		(a)	Upon the written request of Bain Capital from time to time following the first anniversary of an IPO (a
 “Shelf Registration Request”), the Company shall promptly file a shelf Registration Statement with the SEC pursuant
to Rule 415 under the Securities Act (each, a “Shelf Registration Statement”) relating to the offer and sale of
Registrable Securities by Bain Capital from time to time in accordance with the methods of distribution elected by Bain Capital, and the
Company shall use its reasonable best efforts to cause such Shelf Registration Statement to promptly become effective under the Securities
Act. Any such Registration pursuant to a Shelf Registration Request shall hereinafter be referred to as a “Shelf Registration.”

 

		(b)	If on the date of the Shelf Registration Request contemplating the filing of a Shelf Registration Statement
the Company is a WKSI, then the Shelf Registration Request may request Registration with the SEC of an unspecified amount of Registrable
Securities to be sold by unspecified Holders. If on the date of the Shelf Registration Request the Company is not a WKSI, then the Shelf
Registration Request shall specify the aggregate amount of Registrable Securities to be registered. The Company shall provide to Bain
Capital the information necessary to determine the Company’s status as a WKSI upon request.

 

Section 3.2.2      Shelf
Registration Notice. Promptly upon receipt of a Shelf Registration Request (but in no event more than two (2) Business Days
thereafter (or such shorter period as may be reasonably requested in connection with an underwritten “block trade”)), the
Company shall deliver a written notice (a “Shelf Registration Notice”) of any such request to all other Holders, which
notice shall specify, if applicable, the amount of Registrable Securities to be registered, and the Shelf Registration Notice shall offer
each such Holder the opportunity to include in the Shelf Registration that number of Registrable Securities as each such Holder may request
in writing. The Company shall include in such Shelf Registration all such Registrable Securities with respect to which the Company has
received written requests for inclusion therein within two (2) Business Days (or such shorter period as may be reasonably requested
in connection with an underwritten “block trade,” provided such period is at least 24 hours) after the date that the Shelf
Registration Notice has been delivered. The Company will, as expeditiously as possible (and in any event within ten (10) days after
the receipt of a Shelf Registration Notice), use its best efforts to facilitate such Shelf Registration.

 

Section 3.2.3      Continued
Effectiveness of Shelf Registration Statement. The Company shall use its reasonable best efforts to keep any Shelf Registration Statement
continuously effective under the Securities Act in order to permit the Prospectus forming part of the Shelf Registration Statement to
be usable by Holders until the earlier of: (i) the date as of which all Registrable Securities have been sold pursuant to the Shelf
Registration Statement as part of another Registration (but in no event prior to the applicable period referred to in Section 4(a)(3) of
the Securities Act and Rule 174 thereunder); and (ii) the date as of which no Holder holds Registrable Securities (such period
of effectiveness, the “Shelf Period”). Subject to Section 3.2.4, the Company shall be deemed not to have
used its reasonable best efforts to keep the Shelf Registration Statement effective during the Shelf Period if the Company voluntarily
takes any action or omits to take any action that would result in Holders of the Registrable Securities covered thereby not being able
to offer and sell any Registrable Securities pursuant to such Shelf Registration Statement during the Shelf Period, unless such action
or omission is required by applicable law.

 

    	 	 8	 

     

    

 

Section 3.2.4      Suspension
of Shelf Registration. If the continued use of such Shelf Registration Statement at any time would require the Company to make an
Adverse Disclosure, the Company may, upon giving prompt written notice of such action to the Holders, suspend use of the Shelf Registration
Statement (a “Shelf Suspension”); provided, however, that the Company shall not be permitted to exercise a Shelf Suspension
more than one time during any twelve (12)-month period for a period not to exceed sixty (60) days. In the case of a Shelf Suspension,
the Holders agree to suspend use of the applicable Prospectus in connection with any sale or purchase of, or offer to sell or purchase,
Registrable Securities, upon receipt of the notice referred to above. The Company shall immediately notify the Holders in writing upon
the termination of any Shelf Suspension, amend or supplement the Prospectus, if necessary, so it does not contain any untrue statement
or omission of a material fact and furnish to the Holders such numbers of copies of the Prospectus as so amended or supplemented as the
Holders may reasonably request. The Company shall, if necessary, supplement or amend the Shelf Registration Statement, if required by
the registration form used by the Company for the Shelf Registration Statement or by the instructions applicable to such registration
form or by the Securities Act or the rules or regulations promulgated thereunder or as may reasonably be requested by the Holders
of a majority of Registrable Securities that are included in such Shelf Registration Statement.

 

Section 3.2.5      Shelf
Takedown.

 

		(a)	At any time the Company has an effective Shelf Registration Statement with respect to Bain Capital’s
Registrable Securities, by notice to the Company specifying the intended method or methods of disposition thereof, Bain Capital may make
a written request (a “Shelf Takedown Request”) to the Company to effect a Public Offering, including an Underwritten
Shelf Takedown, of all or a portion of such Registrable Securities that may be registered under such Shelf Registration Statement, and
as soon as practicable the Company shall amend or supplement the Shelf Registration Statement as necessary for such purpose.

 

    	 	 9	 

     

    

 

		(b)	Promptly upon receipt of a Shelf Takedown Request (but in no event more than two (2) Business Days
thereafter (or such shorter period as may be reasonably requested in connection with an underwritten “block trade”)) for any
Underwritten Shelf Takedown, the Company shall deliver a notice (a “Shelf Takedown Notice”) to each other Holder with
Registrable Securities covered by the applicable Registration Statement, or to all other Holders if such Registration Statement is undesignated
(each a “Potential Takedown Participant”). The Shelf Takedown Notice shall offer each such Potential Takedown Participant
the opportunity to include in any Underwritten Shelf Takedown such number of Registrable Securities as each such Potential Takedown Participant
may request in writing. The Company shall include in the Underwritten Shelf Takedown all such Registrable Securities with respect to which
the Company has received written requests for inclusion therein within one (1) Business Day (or such shorter period as may be reasonably
requested by Bain Capital in connection with an underwritten “block trade,” provided such period is at least 24 hours) after
the date that the Shelf Takedown Notice has been delivered. Any Potential Takedown Participant’s request to participate in an Underwritten
Shelf Takedown shall be binding on the Potential Takedown Participant; provided that each such Potential Takedown Participant that
elects to participate may condition its participation on the Underwritten Shelf Takedown being completed within fifteen (15) Business
Days of its acceptance. Notwithstanding the delivery of any Shelf Takedown Notice, all determinations as to whether to complete any Underwritten
Shelf Takedown and as to the timing, manner, price and other terms of any Underwritten Shelf Takedown contemplated by this Section 3.2.5
shall be determined by Bain Capital. Bain Capital will have the right to select the investment banker(s) and manager(s) to administer
any underwritten offering in connection with any Shelf Offering.

 

		(c)	Notwithstanding (a) and (b), if Bain Capital wishes to engage in an underwritten block trade or bought
deal off of a Shelf Registration Statement (either through filing an automatic Shelf Registration Statement or through a take-down from
an already existing Shelf Registration Statement) (each, an “Underwritten Block Trade”), then no Holder (other than
Bain Capital) will be permitted to participate in such Underwritten Block Trade without the consent of Bain Capital, except as may otherwise
be provided in any other agreement between the Company and a Holder.

 

Section 3.2.6      Priority
of Securities Sold Pursuant to Shelf Takedowns. If the managing underwriter or underwriters of a proposed Underwritten Shelf Takedown
pursuant to Section 3.2.5 advise the Company in writing that, in its or their opinion, the number of securities requested
to be included in the proposed Underwritten Shelf Takedown exceeds the number that can be sold in such Underwritten Shelf Takedown without
being likely to have an adverse effect on the price, timing or distribution of the securities offered or the market for the securities
offered, the number of Registrable Securities to be included in such offering shall be allocated to the Holders based on each such Holder’s
Pro Rata Portion of the number of Registrable Securities that, in the opinion of such managing underwriter or underwriters, can be sold
without having such adverse effect.

 

Section 3.2.7      Resale
Rights. In the event that Bain Capital elects to request a Registration pursuant to this Section 3.2 in connection with
a distribution of Registrable Securities to its partners or members, the Registration shall provide for resale by such partners or members,
if requested by Bain Capital.

 

    	 	 10	 

     

    

 

Section 3.3         Piggyback
Registration.

 

Section 3.3.1      Participation.
If the Company at any time following its IPO proposes to file a Registration Statement with respect to any offering of its equity securities
for its own account or for the account of Bain Capital under the Securities Act, or to otherwise conduct a Public Offering with respect
to any offering of its equity securities for its own account or for the account of any other Person (other than (i) a Registration
under Section 3.1 or 3.2 (ii) a Registration on Form S-4 or Form S-8 or any successor form to such
forms or (iii) a Registration of securities solely relating to an offering and sale to employees or directors of the Company or
its subsidiaries pursuant to any employee stock plan or other employee benefit plan arrangement), then, as soon as practicable (but in
no event less than ten (10) Business Days prior to the proposed date of filing of the Registration Statement in respect of such
offering or, in the case of a Public Offering under a Shelf Registration Statement, the anticipated pricing or trade date), the Company
shall give written notice (a “Piggyback Notice”) of such proposed filing or Public Offering to all Holders, and such
Piggyback Notice shall offer the Holders the opportunity to register under any such Registration Statement, or to include in such Public
Offering, such number of Registrable Securities as each such Holder may request in writing (a “Piggyback Registration”).
Subject to Section 3.3.2, the Company shall include in such Registration Statement or in such Public Offering, as applicable,
all such Registrable Securities that are requested to be included therein within five (5) days after the receipt by such Holder
of any such notice; provided, however, that if at any time after giving written notice of its intention to register or sell any securities
and prior to the effective date of the Registration Statement filed in connection with such Registration, or the pricing or trade date
of a Public Offering under a Shelf Registration Statement, the Company determines for any reason not to register or sell or to delay
the Registration or sale of such securities, the Company shall give written notice of such determination to each Holder and, thereupon,
(i) in the case of a determination not to register or sell, shall be relieved of its obligation to register or sell any Registrable
Securities in connection with such Registration or Public Offering (but not from its obligation to pay the Registration Expenses in connection
therewith), without prejudice, however, to the rights of any Holders entitled to request that such Registration or sale be effected as
a Demand Registration under Section 3.1 (including pursuant to Section 3.2.8(c)) or an Underwritten Shelf Takedown under
Section 3.2, as the case may be, and (ii) in the case of a determination to delay Registration or sale, in the absence
of a request for a Demand Registration or an Underwritten Shelf Takedown, as the case may be, shall be permitted to delay registering
or selling any Registrable Securities, for the same period as the delay in registering or selling such other securities. Any Holder shall
have the right to withdraw all or part of its request for inclusion of its Registrable Securities in a Piggyback Registration by giving
written notice to the Company of its request to withdraw. If any Piggyback Registration is an underwritten offering, the selection of
investment banker(s) and manager(s) for the offering must be approved by Bain Capital.

 

Section 3.3.2      Priority
of Piggyback Registration. If the managing underwriter or underwriters of any proposed offering of Registrable Securities included
in a Piggyback Registration informs the Company and the participating Holders in writing that, in its or their opinion, the number of
securities that such Holders and any other Persons intend to include in such offering exceeds the number that can be sold in such offering
without being likely to have a significant adverse effect on the price, timing or distribution of the securities offered or the market
for the securities offered, then the securities to be included in such Registration shall be (i) first, one hundred percent (100%)
of the securities that the Company proposes to sell, and (ii) second, and only if all the securities referred to in clause (i) have
been included, then the number of Registrable Securities to be included in such Registration shall be allocated to the Holders based
on each such Holder’s Pro Rata Portion of the number of Registrable Securities that, in the opinion of such managing underwriter
or underwriters, can be sold without having such adverse effect.

 

    	 	 11	 

     

    

 

Section 3.3.3      No
Effect on Other Registrations. No Registration of Registrable Securities effected pursuant to a request under this Section 3.3
shall be deemed to have been effected pursuant to Section 3.1 and 3.2 or shall relieve the Company of its obligations
under Section 3.1 and 3.2.

 

Section 3.4         Lock-Up
Agreements.

 

Section 3.4.1      In
connection with any Underwritten Public Offering (including an IPO), each Holder will enter into any lock-up, holdback or similar
agreements requested by the underwriter(s) managing such offering, in each case with such modifications and exceptions as may be
approved by Bain Capital (including a carve-out to facilitate any Charitable Gifting Event by Bain Capital). Without limiting the generality
of the foregoing, each Holder agrees that in connection with an IPO and any Demand Registration, Shelf Registration or Piggyback Registration
that is an Underwritten Public Offering of the Company’s equity securities and in which Registrable Securities are included, he,
she or it shall not (i) offer, sell, contract to sell, pledge or otherwise dispose of (including sales pursuant to Rule 144),
directly or indirectly, any equity securities of the Company (including equity securities of the Company that may be deemed to be owned
beneficially by such holder in accordance with the rules and regulations of the SEC (collectively, “Securities”),
or any securities, options, or rights convertible into or exchangeable or exercisable for Securities (collectively, “Other Securities”),
(ii) enter into a transaction which would have the same effect as any action described in the foregoing clause (i), (iii) enter
into any swap, hedge or other arrangement that Transfers, in whole or in part, any of the economic consequences or ownership of any Securities
or Other Securities, whether such transaction is to be settled by delivery of such Securities, Other Securities, in cash or otherwise,
or (iv) publicly disclose the intention to enter into any transaction described in the foregoing clauses (i), (ii) or (iii),
from the date on which the Company gives notice to the Holders that a preliminary prospectus has been circulated for such Underwritten
Public Offering to the date that is 180 days following the date of the final prospectus for such Underwritten Public Offering in the case
of an IPO, or 90 days following the date of the final prospectus for such Underwritten Public Offering other than an IPO (or in each case
such shorter period as agreed to by the managing underwriters of such public offering), unless such book runners otherwise agree in writing
(each such period referred to herein as a “Holdback Period”). If (x) the Company issues an earnings release or
other material news or a material event relating to the Company occurs during the last 17 days of the Holdback Period or (y) prior
to the expiration of the Holdback Period, the Company announces that it will release earnings results during the 16 day period beginning
upon the expiration of the Holdback Period, then to the extent necessary for a managing or co-managing underwriter of a registered
offering required hereunder to comply with Rule 2711(f)(4) of the National Association of Securities Dealers, Inc., the
Holdback Period shall be extended until 18 days after the earnings release or the occurrence of the material news or event, as the case
may be (each such period referred to herein as a “Holdback Extension Period”). The Company may impose stop Transfer
instructions with respect to its securities that are subject to the foregoing restriction until the end of such period, including any
Holdback Extension Period.

 

Section 3.4.2      The
Company shall not effect any public sale or distribution of its equity securities, or any securities, options or rights convertible into
or exchangeable or exercisable for such equity securities, during the seven days prior to and during the 180 day period beginning on the
effective date of any underwritten Demand Registration or any underwritten Piggyback Registration (except as part of such underwritten
registration or pursuant to registrations on Form S-4 or Form S-8 or any successor form) or, in the event of a Holdback
Extension Period, for such longer period until the end of such Holdback Extension Period, unless the underwriters managing such public
offering otherwise agree.

 

    	 	 12	 

     

    

 

 

Section 3.4.3          Notwithstanding
anything to the contrary herein, except in the case of (i) a Transfer to the Company, (ii) a Transfer by Bain Capital to its
partners in connection with a pro rata in-kind distribution thereto or in connection with a Charitable Gifting Event, or (iii) a
public sale permitted hereunder (each of clauses (i) through (iii), a “Permitted Transfer”), prior to Transferring
any Registrable Securities to any Person (including by operation of law), the Holder making such Transfer shall cause the prospective
transferee to execute and deliver to the Company a counterpart of this Agreement thereby agreeing to be bound by the terms hereof to
the same extent as the Holder making such Transfer. Any Transfer or attempted Transfer of any Registrable Securities in violation of
any provision of this Agreement shall be void, and the Company shall not record such Transfer on its books or treat any purported transferee
of such securities as the owner of such securities for any purpose. Other than in the case of a Permitted Transfer, whether or not any
such transferee has executed a counterpart hereto, such transferee shall be subject to the obligations of the transferor hereunder.

 

		Section 3.5     	Registration
                                            Procedures.

 

Section 3.5.1         Requirements.
In connection with the Company’s obligations under Sections 3.1 to 3.4, the Company shall use its reasonable best
efforts to effect such Registration and to permit the offering, sale and distribution of such Registrable Securities in accordance with
the intended method or methods of distribution thereof as expeditiously as reasonably practicable, and in connection therewith the Company
shall:

 

		(a)	As promptly as practicable prepare the
                                            required Registration Statement and Prospectus including all exhibits, financial statements
                                            and ancillary materials required under the Securities Act to be filed therewith, and, before
                                            filing a Registration Statement, Prospectus, or any amendments or supplements thereto, (x) furnish
                                            to the underwriters, if any, and to the Holders of the Registrable Securities covered by
                                            such Registration Statement, copies of all documents prepared to be filed, which documents
                                            shall be subject to the review of such underwriters and such Holders and their respective
                                            counsel, (y) make such changes in such documents concerning the Holders prior to the
                                            filing thereof as such Holders, or their counsel, may reasonably request and (z) except
                                            in the case of a Registration under Section 3.3, not file any Registration Statement,
                                            Prospectus, or amendments or supplements thereto to which the participating Holders, in such
                                            capacity, or the underwriters, if any, shall reasonably object;

 

		(b)	prepare and file with the SEC such amendments
                                            and post-effective amendments to the Registration Statement, such supplements to the Prospectus
                                            and such amendments and supplements as may be (x) reasonably requested by any Holder
                                            with Registrable Securities covered by such Registration (y) reasonably requested by
                                            any participating Holder (to the extent such request relates to information relating to such
                                            Holder), or (z) necessary to keep such Registration Statement effective for the period
                                            of time required by this Agreement or to continue to qualify such Registrable Securities
                                            for distribution as required by this Agreement, and comply with provisions of the applicable
                                            securities laws with respect to the sale or other disposition of all securities covered by
                                            such Registration during such period in accordance with the intended method or methods of
                                            disposition by the sellers thereof;

 

     13 

      

    

 

		(c)	notify the participating Holders and the
                                            managing underwriter or underwriters, if any, and (if requested) confirm such notice in writing
                                            and provide copies of the relevant documents, as soon as reasonably practicable after notice
                                            thereof is received by the Company (a) when the applicable Registration Statement or
                                            any amendment thereto has been filed or becomes effective, and when the applicable Prospectus
                                            or any amendment or supplement thereto has been filed, (b) of any written comments by
                                            the SEC, or any request by the SEC or other federal or state governmental authority for amendments
                                            or supplements to such Registration Statement or such Prospectus, or for additional information
                                            (whether before or after the effective date of the Registration Statement) or any other correspondence
                                            with the SEC relating to, or which may affect, the Registration, (c) of the issuance
                                            by the SEC of any stop order suspending the effectiveness of such Registration Statement
                                            or any order by the SEC or any other regulatory authority preventing or suspending the use
                                            of any Prospectus or the initiation or threatening of any proceedings for such purposes and
                                            (d) of the receipt by the Company of any notification with respect to the suspension
                                            of the qualification of the Registrable Securities for offering or sale in any jurisdiction
                                            or the initiation or threatening of any proceeding for such purpose;

 

		(d)	promptly notify each selling Holder and
                                            the managing underwriter or underwriters, if any, when the Company becomes aware of the happening
                                            of any event as a result of which any applicable Registration Statement or the Prospectus
                                            included in such Registration Statement (as then in effect) contains any untrue statement
                                            of a material fact or omits to state a material fact necessary to make the statements therein
                                            (in the case of such Prospectus or any preliminary Prospectus, in light of the circumstances
                                            under which they were made) not misleading, or as a result of which any marketing materials
                                            would contain a misrepresentation or a statement otherwise misleading or untrue, when any
                                            Issuer Free Writing Prospectus includes information that may conflict with the information
                                            contained in the Registration Statement or, if for any other reason it shall be necessary
                                            during such time period to amend or supplement such Registration Statement, Prospectus, in
                                            order to comply with the Securities Act and, as promptly as reasonably practicable thereafter,
                                            prepare and file with the SEC, and furnish without charge to the selling Holders and the
                                            managing underwriter or underwriters, if any, an amendment or supplement to such Registration
                                            Statement or Prospectus, which shall correct such misstatement or omission or effect such
                                            compliance;

 

		(e)	to the extent the Company is eligible
                                            under the relevant provisions of Rule 430B under the Securities Act, if the Company
                                            files any Shelf Registration Statement, the Company shall include in such Shelf Registration
                                            Statement such disclosures as may be required by Rule 430B under the Securities Act
                                            (referring to the unnamed selling security holders in a generic manner by identifying the
                                            initial offering of the securities to the Holders) in order to ensure that the Holders may
                                            be added to such Shelf Registration Statement at a later time through the filing of a Prospectus
                                            supplement rather than a post-effective amendment;

 

     14 

      

    

 

		(f)	use its reasonable best efforts to prevent,
                                            or obtain the withdrawal of, any stop order or other order or notice preventing or suspending
                                            the use of any preliminary or final Prospectus;

 

		(g)	promptly incorporate in a Prospectus supplement, Issuer
                                            Free Writing Prospectus or post-effective amendment such information as the managing underwriter
                                            or underwriters and the selling Holders agree should be included therein relating to the
                                            plan of distribution with respect to such Registrable Securities; and make all required filings
                                            of such Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment
                                            as soon as reasonably practicable after being notified of the matters to be incorporated
                                            in such Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment;

 

		(h)	furnish to each selling Holder and each
                                            underwriter, if any, without charge, as many conformed copies as such Holder or underwriter
                                            may reasonably request of any applicable Registration Statement and any amendment or post-effective
                                            amendment or supplement thereto, including financial statements and schedules, all documents
                                            incorporated therein by reference and all exhibits (including those incorporated by reference);

 

		(i)	deliver to each selling Holder and each
                                            underwriter, if any, without charge, as many copies of any applicable Prospectus (including
                                            each preliminary Prospectus) and any amendment or supplement thereto and such other documents
                                            as such Holder or underwriter may reasonably request in order to facilitate the disposition
                                            of the Registrable Securities by such Holder or underwriter (it being understood that the
                                            Company shall consent to the use of such Prospectus or any amendment or supplement thereto
                                            by each of the selling Holders and the underwriters, if any, in connection with the offering,
                                            sale or distribution of the Registrable Securities covered by such Prospectus or any amendment
                                            or supplement thereto);

 

		(j)	on or prior to the date on which any applicable
                                            Registration Statement becomes effective. use its reasonable best efforts to register or
                                            qualify, and cooperate with the selling Holders, the managing underwriter or underwriters,
                                            if any, and their respective counsel, in connection with the Registration or qualification
                                            of such Registrable Securities for offer and sale under the securities or “Blue Sky”
                                            laws of each state and other jurisdiction as any such selling Holder or managing underwriter
                                            or underwriters, if any, or their respective counsel reasonably request in writing and do
                                            any and all other acts or things reasonably necessary or advisable to keep such Registration
                                            or qualification in effect for such period as required by Section 3.1 or Section 3.2,
                                            as applicable, provided that the Company shall not be required to qualify generally to do
                                            business in any jurisdiction where it is not then so qualified or to take any action which
                                            would subject it to taxation or general service of process in any such jurisdiction where
                                            it is not then so subject;

 

     15 

      

    

 

		(k)	cooperate with the selling Holders and
                                            the managing underwriter or underwriters, if any, to facilitate the timely preparation and
                                            delivery of certificates representing Registrable Securities to be sold and enable such Registrable
                                            Securities to be in such denominations and registered in such names as the managing underwriters
                                            may request prior to any sale of Registrable Securities to the underwriters;

 

		(l)	use its reasonable best efforts to cause
                                            the Registrable Securities covered by the applicable Registration to be registered with or
                                            approved by such other governmental agencies or authorities as may be necessary to enable
                                            the seller or sellers thereof or the underwriter or underwriters, if any, to consummate the
                                            disposition of such Registrable Securities;

 

		(m)	not later than the effective date of any
                                            applicable Registration Statement, provide a CUSIP number for all Registrable Securities
                                            and, as applicable, provide the applicable transfer agent with printed certificates for the
                                            Registrable Securities which are in a form eligible for deposit with The Depository Trust
                                            Company;

 

		(n)	make such representations and warranties
                                            to the Holders of which Registrable Securities are being registered, and the underwriters
                                            or agents, if any, in form, substance and scope as are customarily made by issuers in public
                                            offerings similar to the offering then being undertaken;

 

		(o)	enter into such customary agreements (including
                                            underwriting and indemnification agreements) and take all such other actions as the selling
                                            Holders or the managing underwriter or underwriters, if any, reasonably request in order
                                            to expedite or facilitate the Registration and disposition of such Registrable Securities;

 

		(p)	obtain for delivery to the Holders of
                                            the Registrable Securities being registered and to the underwriter or underwriters, if any,
                                            an opinion or opinions from counsel for the Company dated the most recent effective date
                                            of any Registration Statement or, in the event of an Underwritten Public Offering or if customary
                                            in public offerings similar to the offering then being undertaken, the date of the closing
                                            under the underwriting agreement or for such offering, in customary form, scope and substance,
                                            which opinions shall be reasonably satisfactory to such Holders or underwriters, as the case
                                            may be, and their respective counsel;

 

		(q)	in the case of an Underwritten Public
                                            Offering, obtain for delivery to the Company and the managing underwriter or underwriters,
                                            with copies to the Holders included in such Registration or sale, a comfort letter from the
                                            Company’s independent certified public accountants or independent auditors (and, if
                                            necessary, any other independent certified public accountants or independent auditors of
                                            any subsidiary of the Company or any business acquired by the Company for which financial
                                            statements and financial data are, or are required to be, included in the Registration Statement)
                                            in customary form and covering such matters of the type customarily covered by comfort letters
                                            as the managing underwriter or underwriters reasonably request, dated the date of execution
                                            of the underwriting agreement and brought down to the closing under the underwriting agreement;

 

     16 

      

    

 

		(r)	cooperate with each seller of Registrable
                                            Securities and each underwriter, if any, participating in the disposition of such Registrable
                                            Securities and their respective counsel in connection with any filings required to be made
                                            with FINRA;

 

		(s)	use its reasonable best efforts to comply
                                            with all applicable securities laws and, if a Registration Statement was filed, make available
                                            to its security holders, as soon as reasonably practicable, an earnings statement satisfying
                                            the provisions of Section 11(a) of the Securities Act and the rules and regulations
                                            promulgated thereunder;

 

		(t)	provide and cause to be maintained a transfer
                                            agent and registrar for all Registrable Securities covered by such Registration;

 

		(u)	use its reasonable best efforts to cause
                                            all Registrable Securities covered by such Registration to be listed on each securities exchange
                                            on which any of the Company’s equity securities are then listed or quoted and on each
                                            inter-dealer quotation system on which any of the Company’s equity securities are then
                                            quoted;

 

		(v)	make available upon reasonable notice
                                            at reasonable times and for reasonable periods for inspection by a representative appointed
                                            by the selling Holders, by any underwriter participating in any Registration and by any attorney,
                                            accountant or other agent retained by such Holders or any such underwriter, all pertinent
                                            financial and other records and pertinent corporate documents and properties of the Company,
                                            and cause all of the Company’s officers, Directors and employees and the independent
                                            public accountants who have certified its financial statements to make themselves available
                                            to discuss the business of the Company and to supply all information reasonably requested
                                            by any such Person in connection with such Registration;

 

		(w)	in the case of an Underwritten Public
                                            Offering, cause the senior executive officers of the Company to participate in the customary
                                            “road show” presentations that may be reasonably requested by the managing underwriter
                                            or underwriters in any such offering and otherwise to facilitate, cooperate with, and participate
                                            in each proposed offering contemplated herein and customary selling efforts related thereto;

 

		(x)	take no direct or indirect action prohibited
                                            by Regulation M under the Exchange Act;

 

		(y)	take all reasonable action to ensure that
                                            any Issuer Free Writing Prospectus utilized in connection with such Registration complies
                                            in all material respects with the Securities Act, is filed in accordance with the Securities
                                            Act to the extent required thereby, is retained in accordance with the Securities Act to
                                            the extent required thereby and, when taken together with the related Prospectus, will not
                                            contain any untrue statement of a material fact or omit to state a material fact necessary
                                            to make the statements therein, in light of the circumstances under which they were made,
                                            not misleading;

 

     17 

      

    

 

		(z)	cooperate with the Holders of Registrable
                                            Securities subject of the Registration Statement and with the managing underwriter or agent,
                                            if any to facilitate any Charitable Gifting Event and to prepare and file with the SEC such
                                            amendments and supplements to such Registration Statement, Prospectus used in connection
                                            therewith as may be necessary to permit any such recipient Charitable Organization to sell
                                            in the Public Offering if it so elects; and

 

		(aa)	take all such other commercially reasonable
                                            actions as are necessary or advisable in order to expedite or facilitate the disposition
                                            of such Registrable Securities in accordance with the terms of this Agreement.

 

Section 3.5.2         Company
Information Requests. The Company may require each seller of Registrable Securities as to which any Registration or sale is being
effected to furnish to the Company such information regarding the distribution of such securities and such other information relating
to such Holder and its ownership of Registrable Securities as the Company may from time to time reasonably request in writing and the
Company may exclude from such Registration or sale the Registrable Securities of any such Holder who unreasonably fails to furnish such
information within a reasonable time after receiving such request. Each Holder agrees to furnish such information to the Company and
to cooperate with the Company as reasonably necessary to enable the Company to comply with the provisions of this Agreement.

 

Section 3.5.3         Discontinuing
Registration. Each Holder agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described
in Section 3.5.1(d), such Holder will discontinue disposition of Registrable Securities pursuant to such Registration Statement
until such Holder’s receipt of the copies of the supplemented or amended Prospectus, or until such Holder is advised in writing
by the Company that the use of the Prospectus may be resumed, and, as applicable, has received copies of any additional or supplemental
filings that are incorporated by reference in the Prospectus, or any amendments or supplements thereto, and if so directed by the Company,
such Holder shall deliver to the Company (at the Company’s expense) all copies, other than permanent file copies then in such Holder’s
possession, of such documents current at the time of receipt of such notice. In the event the Company shall give any such notice, the
period during which any applicable Registration Statement is required to be maintained effective shall be extended by the number of days
during the period from and including the date of the giving of such notice to and including the date when each seller of Registrable
Securities covered by such Registration Statement either receives the copies of the supplemented or amended Prospectus contemplated by
Section 3.5.1(d) or is advised in writing by the Company that the use of the Prospectus may be resumed.

 

		Section 3.6     	Underwritten
                                            Offerings.

 

Section 3.6.1        Shelf
and Demand Registrations. If requested by the underwriters for any Underwritten Public Offering, pursuant to a Registration or sale
under Section 3.1 or 3.2, the Company shall enter into an underwriting agreement with such underwriters, such agreement
to be reasonably satisfactory in substance and form to each of the Company and Bain Capital, and to contain such representations and
warranties by the Company and such other terms as are generally prevailing in agreements of that type, including indemnities no less
favorable to the recipient thereof than those provided in Section 3.9 of this Agreement. The Holders of the Registrable Securities
proposed to be distributed by such underwriters shall cooperate with the Company in the negotiation of the underwriting agreement and
shall give consideration to the reasonable suggestions of the Company regarding the form thereof, and such Holders shall complete and
execute all questionnaires, powers of attorney and other documents reasonably requested by the underwriters and required under the terms
of such underwriting arrangements. Any such Holder shall not be required to make any representations or warranties to or agreements with
the Company or the underwriters other than representations, warranties or agreements regarding such Holder, such Holder’s title
to the Registrable Securities, such Holder’s intended method of distribution and any other representations to be made by the Holder
as are generally prevailing in agreements of that type, and the aggregate amount of the liability of such Holder under such agreement
shall not exceed such Holder’s proceeds from the sale of its Registrable Securities in the offering, net of underwriting discounts
and commissions but before expenses.

 

     18 

      

    

 

Section 3.6.2          Piggyback
Registrations. If the Company proposes to register or sell any of its securities as contemplated by Section 3.3 and such
securities are to be distributed through one or more underwriters, the Company shall, if requested by any Holder pursuant to Section 3.3
and, subject to the provisions of Section 3.3.2, use its reasonable best efforts to arrange for such underwriters to
include on the same terms and conditions that apply to the other sellers in such Registration or sale all the Registrable Securities
to be offered and sold by such Holder among the securities of the Company to be distributed by such underwriters in such Registration
or sale. The Holders of Registrable Securities to be distributed by such underwriters shall be parties to the underwriting agreement
between the Company and such underwriters and shall complete and execute all questionnaires, powers of attorney and other documents reasonably
requested by the underwriters and required under the terms of such underwriting arrangements. Any such Holder shall not be required to
make any representations or warranties to or agreements with the Company or the underwriters other than representations, warranties or
agreements regarding such Holder, such Holder’s title to the Registrable Securities, such Holder’s intended method of distribution
and any other representations to be made by the Holder as are generally prevailing in agreements of that type, and the aggregate amount
of the liability of such Holder shall not exceed such Holder’s proceeds from the sale of its Registrable Securities in the offering,
net of underwriting discounts and commissions but before expenses.

 

Section 3.6.3          Selection
of Underwriters; Selection of Counsel. At a time when Bain Capital is a Holder pursuant to this Agreement, (i) in the case of
an Underwritten Public Offering under Section 3.1 or 3.2 the managing underwriter or underwriters to administer the
offering shall be determined by Bain Capital; (ii) in the case of an Underwritten Public Offering under Section 3.3,
the managing underwriter or underwriters to administer the offering shall be determined by the Company; provided that such underwriter
or underwriters shall be acceptable to Bain Capital; and (iii) in the case of an Underwritten Public Offering under Sections 3.1,
3.2 or 3.3 counsel to the Holders shall be selected by Bain Capital.

 

Section 3.7             No
Inconsistent Agreements; Additional Rights. Neither the Company nor any of its subsidiaries shall hereafter enter into, and neither
the Company nor any of its subsidiaries is currently a party to, any agreement with respect to its securities that is inconsistent with
the rights granted to the Holders by this Agreement unless approved by Bain Capital. Neither the Company nor any of its subsidiaries
shall enter into any agreement granting registration or similar rights to any Person without the approval of Bain Capital hereunder at
the time such agreement is entered into or such grant is agreed to, and the Company hereby represents and warrants that, as of the date
hereof, no registration or similar rights have been granted to any other Person other than pursuant to this Agreement.

 

     19 

      

    

 

Section 3.8             Registration
Expenses. All expenses incident to the Company’s performance of or compliance with this Agreement shall be paid by the Company,
including (i) all registration and filing fees, and any other fees and expenses associated with filings required to be made with
the SEC or FINRA (ii) all fees and expenses in connection with compliance with any securities or “Blue Sky” laws (including
reasonable fees and disbursements of counsel for the underwriters in connection with blue sky qualifications of the Registrable Securities),
(iii) all printing, translation, duplicating, word processing, messenger, telephone, facsimile and delivery expenses (including
all expenses of any transfer agent and expenses relating to The Depository Trust Company and of printing prospectuses or other offering
documents), (iv) all fees and disbursements of counsel for the Company and of all independent certified public accountants or independent
auditors of the Company and any subsidiaries of the Company (including the expenses of any special audit and comfort letters required
by or incident to such performance), (v) Securities Act liability insurance or similar insurance if the Company so desires or the
underwriters so require in accordance with then-customary underwriting practice, (vi) all fees and expenses incurred in connection
with the listing of the Registrable Securities on any securities exchange or quotation of the Registrable Securities on any inter-dealer
quotation system, including Nasdaq, (vii) all reasonable fees and disbursements of legal counsel for the selling Holders, (viii) any
reasonable fees and disbursements of underwriters customarily paid by issuers or sellers of securities, (x) all fees and expenses
incurred in connection with the distribution or Transfer of Registrable Securities to or by a Holder or its Permitted Transferees in
connection with a Public Offering, (xi) all fees and expenses of any special experts or other Persons retained by the Company in
connection with any Registration or sale, (xii) all of the Company’s internal expenses (including all salaries and expenses
of its officers and employees performing legal or accounting duties) and (xiii) all expenses related to any “road show”,
including the reasonable out-of-pocket expenses of the Holders and underwriters, if so requested. All such expenses are referred to herein
as “Registration Expenses”. The Company shall not be required to pay any fees and disbursements to underwriters not
customarily paid by the issuers of securities in an offering similar to the applicable offering, including underwriting discounts and
commissions and transfer taxes, if any, attributable to the sale of Registrable Securities.

 

     20 

      

    

 

Section
3.9            
Indemnification.

 

 

Section 3.9.1          Indemnification
by the Company. The Company shall indemnify and hold harmless, to the full extent permitted by law, each Holder, each shareholder,
member, limited or general partner of such Holder, each shareholder, member, limited or general partner of each such shareholder, member,
limited or general partner, each of their respective Affiliates, officers, directors, managers, shareholders, employees, advisors, and
agents and each Person who controls (within the meaning of the Securities Act or the Exchange Act) or is deemed to control such Persons
and each of their respective Representatives from and against any and all losses, penalties, judgments, suits, costs, claims, damages,
liabilities and expenses, joint or several (including reasonable costs of investigation and legal expenses and any indemnity and contribution
payments made to underwriters ) (each, a “Loss” and collectively “Losses”) arising out of or based
upon (i) (A) any untrue or alleged untrue statement of a material fact contained in any Registration Statement under which
such Registrable Securities are registered or sold under the Securities Act (including any final, preliminary or summary Prospectus contained
therein or any amendment thereof or supplement thereto or any documents incorporated by reference therein), or (B) any omission
or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the
case of a Prospectus or preliminary Prospectus, in light of the circumstances under which they were made) not misleading, (ii) any
untrue or alleged untrue statement of a material fact contained in any other disclosure document produced by or on behalf of the Company
or any of its subsidiaries including any report and other document filed under the Exchange Act or (iii) any violation or alleged
violation by the Company or any of its subsidiaries of any federal, state, provincial, foreign or common law rule or regulation
applicable to the Company or any of its subsidiaries and relating to action or inaction in connection with any such registration, disclosure
document or other document or report; provided, that no selling Holder shall be entitled to indemnification pursuant to this Section 3.9.1
in respect of any untrue statement or omission or any misrepresentation contained in any information relating to such selling Holder
furnished in writing by such selling Holder to the Company specifically for inclusion in a Registration Statement, and used by the Company
in conformity therewith (such information, “Selling Holder Information”). This indemnity shall be in addition to any
liability the Company may otherwise have. Such indemnity shall remain in full force and effect regardless of any investigation made by
or on behalf of such Holder or any indemnified party and shall survive the Transfer of such securities by such Holder and regardless
of any indemnity agreed to in the underwriting agreement that is less favorable to the Holders. The Company shall also indemnify underwriters,
selling brokers, dealer managers and similar securities industry professionals participating in the distribution, their officers and
directors and each Person who controls such Persons (within the meaning of the Securities Act and the Exchange Act) to the same extent
as provided above (with appropriate modification) with respect to the indemnification of the indemnified parties.

 

Section 3.9.2          Indemnification
by the Selling Holders. Each selling Holder agrees (severally and not jointly) to indemnify and hold harmless, to the fullest extent
permitted by law, the Company, its Directors and officers and each Person who controls (within the meaning of the Securities Act or the
Exchange Act) or is deemed to control the Company from and against any Losses resulting from (i) (A) any untrue statement of
a material fact in any Registration Statement under which such Registrable Securities were registered or sold under the Securities Act
(including any final, preliminary or summary Prospectus contained therein or any amendment thereof or supplement thereto or any documents
incorporated by reference therein) or (B) any omission to state therein a material fact required to be stated therein or necessary
to make the statements therein (in the case of a Prospectus or preliminary Prospectus, in light of the circumstances under which they
were made) not misleading, to the extent, but only to the extent, that such untrue statement or omission or such misrepresentation is
contained in such selling Holder’s Selling Holder Information. In no event shall the liability of any selling Holder hereunder
be greater in amount than the dollar amount of the proceeds from the sale of its Registrable Securities in the offering giving rise to
such indemnification obligation, net of underwriting discounts and commissions but before expenses, less any amounts paid by such Holder
pursuant to Section 3.9.4 and any amounts paid by such Holder as a result of liabilities incurred under the underwriting
agreement, if any, related to such sale.

 

     21 

      

    

 

Section 3.9.3          Conduct
of Indemnification Proceedings. Any Person entitled to indemnification hereunder shall (a) give prompt written notice to the
indemnifying party of any claim with respect to which it seeks indemnification (provided that any delay or failure to so notify the indemnifying
party shall relieve the indemnifying party of its obligations hereunder only to the extent, if at all, that it forfeits substantive legal
rights by reason of such delay or failure) and (b) permit such indemnifying party to assume the defense of such claim with counsel
reasonably satisfactory to the indemnified party; provided, however, that any Person entitled to indemnification hereunder shall have
the right to select and employ separate counsel and to participate in the defense of such claim, but the fees and expenses of such counsel
shall be at the expense of such Person unless (i) the indemnifying party has agreed in writing to pay such fees or expenses, (ii) the
indemnifying party shall have failed to assume the defense of such claim within a reasonable time after receipt of notice of such claim
from the Person entitled to indemnification hereunder and employ counsel reasonably satisfactory to such Person, (iii) the indemnified
party has reasonably concluded (based upon advice of its counsel) that there may be legal defenses available to it or other indemnified
parties that are different from or in addition to those available to the indemnifying party, or (iv) in the reasonable judgment
of any such Person (based upon advice of its counsel) a conflict of interest may exist between such Person and the indemnifying party
with respect to such claims (in which case, if the Person notifies the indemnifying party in writing that such Person elects to employ
separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such
claim on behalf of such Person). If the indemnifying party assumes the defense, the indemnifying party shall not have the right to settle
such action without the consent of the indemnified party. No indemnifying party shall consent to entry of any judgment or enter into
any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party
of an unconditional release from all liability in respect to such claim or litigation without the prior written consent of such indemnified
party. If such defense is not assumed by the indemnifying party, the indemnifying party will not be subject to any liability for any
settlement made without its prior written consent, but such consent may not be unreasonably withheld. It is understood that the indemnifying
party or parties shall not, except as specifically set forth in this Section 3.9.3, in connection with any proceeding or
related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements or other charges of more than one separate
firm admitted to practice in such jurisdiction at any one time unless (x) the employment of more than one counsel has been authorized
in writing by the indemnifying party or parties, (y) an indemnified party has reasonably concluded (based on the advice of counsel)
that there may be legal defenses available to it that are different from or in addition to those available to the other indemnified parties
or (z) a conflict or potential conflict exists or may exist (based upon advice of counsel to an indemnified party) between such
indemnified party and the other indemnified parties, in each of which cases the indemnifying party shall be obligated to pay the reasonable
fees and expenses of such additional counsel or counsels.

 

     22 

      

    

 

Section 3.9.4          Contribution.
If for any reason the indemnification provided for in Section 3.9.1 and Section 3.9.2 is unavailable to an indemnified
party or insufficient in respect of any Losses referred to therein (other than as a result of exceptions or limitations on indemnification
contained in Section 3.9.1 and Section 3.9.2), then the indemnifying party shall contribute to the amount paid
or payable by the indemnified party as a result of such Loss in such proportion as is appropriate to reflect the relative fault of the
indemnifying party on the one hand and the indemnified party or parties on the other hand in connection with the acts, statements or
omissions that resulted in such Losses, as well as any other relevant equitable considerations. The relative fault of the indemnifying
party on the one hand and the indemnified party on the other hand shall be determined by reference to, among other things, whether any
untrue or alleged untrue statement of a material fact or misrepresentation or the omission or alleged omission to state a material fact
relates to information supplied by the indemnifying party or by the indemnified party, and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such statement, misrepresentation or omission. The parties hereto agree that
it would not be just or equitable if contribution pursuant to this Section 3.9.4 were determined by pro rata allocation or
by any other method of allocation that does not take account of the equitable considerations referred to in this Section 3.9.4.
No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled
to contribution from any Person who was not guilty of such fraudulent misrepresentation. The amount paid or payable by an indemnified
party as a result of the Losses referred to in Sections 3.9.1 and 3.9.2 shall be deemed to include, subject to the limitations
set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending
any such action or claim. Notwithstanding the provisions of this Section 3.9.4, in connection with any Registration effected
pursuant to this Agreement, a selling Holder shall not be required to contribute any amount in excess of the dollar amount of the proceeds
from the sale of its Registrable Securities in the offering giving rise to such indemnification obligation, net of underwriting discounts
and commissions but before expenses, less any amounts paid by such Holder pursuant to Section 3.9.2 and any amounts paid
by such Holder as a result of liabilities incurred under the underwriting agreement, if any, related to such Registration. If indemnification
is available under this Section 3.9, the indemnifying parties shall indemnify each indemnified party to the full extent provided
in Sections 3.9.1 and 3.9.2 hereof without regard to the provisions of this Section 3.9.4. The remedies provided for in this
Section 3.9 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any indemnified
party at law or in equity.

 

Section 3.9.5          Priority.
The Company hereby acknowledges and agrees that any Person entitled to indemnification pursuant to Section 3.9.1 (a “Company
Indemnitee”) may have certain rights to indemnification, advancement of expenses and/or insurance provided by other sources.
The Company hereby acknowledges and agrees (i) that it is the indemnitor of first resort (i.e., its obligations to a Company Indemnitee
are primary and any obligation of such other sources to advance expenses or to provide indemnification for the same expenses or liabilities
incurred by such Company Indemnitee are secondary) and (ii) that it shall be required to advance the full amount of expenses incurred
by a Company Indemnitee and shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement
to the extent legally permitted and as required by the terms of this Agreement without regard to any rights a Company Indemnitee may
have against such other sources. The Company further agrees that no advancement or payment by such other sources on behalf of a Company
Indemnitee with respect to any claim for which such Company Indemnitee has sought indemnification, advancement of expenses or insurance
from the Company shall affect the foregoing, and that such other sources shall have a right of contribution and/or be subrogated to the
extent of such advancement or payment to all of the rights of recovery of such Company Indemnitee against the Company.

 

     23 

      

    

 

Section 3.10           Rules 144
and 144A. The Company shall file the reports required to be filed by it under the Securities Act and the Exchange Act and the rules and
regulations adopted by the SEC thereunder (or, if the Company is not required to file such reports, it will, upon the request of any
Holder, make publicly available such necessary information for so long as necessary to permit sales that would otherwise be permitted
by this Agreement pursuant to Rule 144 or Rule 144A under the Securities Act, as such rules may be amended from time to
time or any similar rule or regulation hereafter adopted by the SEC), and it will take such further action as any Holder may reasonably
request, all to the extent required from time to time to enable such Holder to sell Registrable Securities without Registration under
the Securities Act in transactions that would otherwise be permitted by this Agreement and within the limitation of the exemptions provided
by (i) Rule 144 or Rule 144A under the Securities Act, as such rules may be amended from time to time, or (ii) any
similar rule or regulation hereafter adopted by the SEC. Upon the request of any Holder, the Company will deliver to such Holder
a written statement as to whether it has complied with such requirements and, if not, the specifics thereof. Existing Registration Statements.
Notwithstanding anything herein to the contrary and subject to applicable law and regulation, the Company may satisfy any obligation
hereunder to file a Registration Statement or to have a Registration Statement become effective by a specified date by designating, by
notice to the Holders, a Registration Statement that previously has been filed with the SEC or become effective, as the case may be,
as the relevant Registration Statement or Prospectus for purposes of satisfying such obligation, and all references to any such obligation
shall be construed accordingly; provided that such previously filed Registration Statement may be, and is, amended or, subject to applicable
securities laws, supplemented to add the number of Registrable Securities, and, to the extent necessary, to identify as selling shareholders
those Holders demanding the filing of a Registration Statement pursuant to the terms of this Agreement. To the extent this Agreement
refers to the filing or effectiveness of other Registration Statements, by or at a specified time and the Company has, in lieu of then
filing such Registration Statements or having such Registration Statements become effective, designated a previously filed or effective
Registration Statement as the relevant Registration Statement for such purposes, in accordance with the preceding sentence, such references
shall be construed to refer to such designated Registration Statement, as amended or supplemented in the manner contemplated by the immediately
preceding sentence.

 

Article IV

GOVERNANCE

 

Section 4.1            Board
Nomination Rights.

 

Section 4.1.1         Size
and Composition of the Board. As of the closing of the IPO, the Board shall consist of nine (19) Directors, comprised of Philip Wieland,
Selim Bassoul, Robert Farkas, Juan Figuereo, Eric Foss, Ken Hanau, Susan Levine, Jonathon Penn and Michel Plantevin; provided that the
Board shall further increase the number of Independent Directors to the extent necessary to comply with applicable law and the rules and
regulations of Nasdaq, or as otherwise agreed by the Board, subject to the rights of Bain Capital under Section 4.1.2.

 

Section 4.1.2        Bain
Capital Nomination Rights. Pursuant to the terms and subject to the conditions of this Section 4.1 and applicable law,
the rights of Bain Capital to nominate Directors (including in respect of any Director Election Meeting) shall be as follows:

 

		(a)	so long as Bain Capital beneficially owns,
                                            directly or indirectly, at least 40% of the aggregate number of outstanding Ordinary Shares
                                            immediately following the closing of an IPO, Bain Capital shall be entitled to nominate a
                                            majority of the Directors;

 

     24 

      

    

 

		(b)	so long as Bain Capital beneficially owns,
                                            directly or indirectly, at least 30% (but less than 40%) of the aggregate number of outstanding
                                            Ordinary Shares immediately following the closing of an IPO (the “30% Ownership
                                            Threshold”), Bain Capital shall be entitled to nominate a number of Directors equal
                                            to 40% of all Directors (rounded up to the nearest whole number);

 

		(c)	so long as Bain Capital beneficially owns,
                                            directly or indirectly, at least 20% (but less than 30%) of the aggregate number of outstanding
                                            Ordinary Shares immediately following the closing of an IPO, Bain Capital shall be entitled
                                            to nominate a number of Directors equal to 30% of all Directors (rounded up to the nearest
                                            whole number);

 

		(d)	so long as Bain Capital beneficially owns,
                                            directly or indirectly, at least 10% (but less than 20%) of the aggregate number of outstanding
                                            Ordinary Shares immediately following the closing of an IPO, Bain Capital shall be entitled
                                            to nominate a number of Directors equal to 20% of all Directors (rounded up to the nearest
                                            whole number), but in no event fewer than two Directors; and

 

		(e)	so long as Bain Capital beneficially owns,
                                            directly or indirectly, at least 2% (but less than 10%) of the aggregate number of outstanding
                                            Ordinary Shares immediately following the closing of an IPO, Bain Capital shall be entitled
                                            to nominate one Director.

 

No reduction in the number
of Ordinary Shares that Bain Capital beneficially owns shall shorten the term of any incumbent director.

 

Section 4.1.3         Nomination
and Election Procedures. The Company shall notify Bain Capital of its intent to hold a Director Election Meeting at least 60 Business
Days prior to the date of such Director Election Meeting. Bain Capital may notify the Company of its nominees pursuant to Section 4.1.2
at any time but no less than 25 Business Days prior to the date of any Director Election Meeting. If, prior to the Director Election
Meeting, a nominee of Bain Capital is unable or unwilling to serve as a Director, then Bain Capital will be entitled to designate an
alternative nominee.

 

Section 4.1.4         Other
Nominees. The selection of nominees to serve as Directors other than the nominees designated by Bain Capital pursuant to Section 4.1.2
(including when any designation right of Bain Capital has not been exercised pursuant thereto), shall rest with the Board, or the
Nominating and Governance Committee, if so determined by the Board.

 

Section 4.1.5          Replacement
Appointment. If any Bain Director resigns, is removed, or is unable to serve for any reason prior to the expiration of his or her
term as a Director, then Bain Capital shall be entitled to designate a replacement to be appointed by the Board as Director as soon as
reasonably practicable (regardless of Bain Capital’s beneficial ownership in the Company at the time of such vacancy); it being
understood that any such designee shall serve the remainder of the term of the Director whom such designee replaces.

 

Section 4.1.6         Qualifications.
Notwithstanding anything to the contrary in this Agreement, all Directors (including Bain Directors) shall, at all times while serving
on the Board, meet the qualification requirements to serve as a director under applicable securities laws and the rules and regulations
of Nasdaq.

 

     25 

      

    

 

Section 4.1.7         Chairman.
Bain Capital shall have the right to designate the Chairman of the Board for so long as Bain Capital satisfies the 30% Ownership Threshold.

 

Section 4.2            Board
Committees. The committees of the Board shall consist of an Audit Committee, a People Resources Committee and Nominating and Governance
Committee, and such other committees as the Board may establish from time to time; provided that the People Resources Committee and the
Nominating and Governance Committee may be combined into a single committee if determined by the Board. Bain Capital shall have the right
to designate (i) a majority of the Directors serving on each committee for so long as Bain Capital satisfies the 30% Ownership Threshold
and (ii) at least one Director serving on each committee for so long as Bain Capital has the right to nominate as least one Director
under Section 4.1.2; provided that, in each case, the composition of each committee shall comply with applicable securities
laws and the rules and regulations of Nasdaq. Subject to the foregoing, all members of the committees of the Board shall be selected
by the Board.

 

Section 4.3            Expenses;
D&O Insurance. The Company shall reimburse the members of the Board for all reasonable out-of-pocked expenses incurred in connection
with the attendance at meetings of the Board and any committees thereof, including without limitation, travel, lodging and meal expenses.
The Company shall obtain director and officer liability insurance reasonably satisfactory to Bain Capital.

 

Section 4.4            Written
Consent or Resolutions. The provisions of this ARTICLE IV applicable to Director Election Meetings shall apply mutatis mutandis
to any written consent or resolutions of shareholders relating to the election of Directors.

 

Section 4.5            Remedies.
Without limiting the generality of Section 5.5, each party hereto acknowledges that a breach or threatened breach by a party
of any provision of this Article IV will result in the other parties suffering irreparable harm which cannot be calculated or fully
or adequately compensated by recovery of damages alone. Accordingly, each party agrees that the other parties shall be entitled to interim
and permanent injunctive relief, specific performance and other equitable remedies, in addition to any other relief to which it or any
other party may become entitled.

 

     26 

      

    

 

Section 4.6            Company
Obligations. The Company agrees to use its reasonable best efforts to ensure that, so long as Bain Capital has the right to nominate
a Director under Section 4.1.2, (i) each nominee proposed by Bain Capital is included in the Board’s slate of
nominees to the shareholders (the “Board’s Slate”) for each Director Election Meeting, and (ii) each nominee
proposed by Bain Capital is included in the proxy statement prepared by the Company in connection with soliciting proxies for every Director
Election Meeting (each, a “Director Election Proxy Statement”), and at every adjournment or postponement thereof.
The calculation of the number of nominees that Bain Capital is entitled to nominate to the Board’s Slate for any Director Election
Meeting shall be based on Bain Capital’s beneficial ownership of Ordinary Shares immediately prior to mailing to shareholders of
the Company the Director Election Proxy Statement relating to such election (or, if earlier, the filing of the definitive Director Election
Proxy Statement with the SEC). Unless Bain Capital notifies the Company otherwise prior to the mailing to shareholders of the Director
Election Proxy Statement relating to an election of Directors, the Nominees for such election shall be presumed to be the same nominees
currently serving on the Board, and no further action shall be required of Bain Capital for the Board to include such nominees on the
Board’s Slate; provided, that, in the event Bain Capital is no longer entitled to nominate the full number of nominees then serving
on the Board, Bain Capital shall provide advance written notice to the Company of which currently servicing nominee(s) shall be
excluded from the Board Slate, and of any other changes to the list of nominees. Furthermore, the Company agrees for so long as the Company
qualifies as a “controlled company” under the rules and regulations of Nasdaq, the Company will elect to be a “controlled
company” for purposes of such rules and regulations and will disclose in its annual meeting proxy statement that it is a “controlled
company” and the basis for that determination. If the Company ceases to qualify as a “controlled company” under the
rules and regulations of Nasdaq, Bain Capital and the Company shall take whatever action may be reasonably necessary in relation
to such party, if any, to cause the Company to comply with such rules and regulations as then in effect within the timeframe for
compliance available under such rules and regulations, including any applicable transition periods.

 

Article V

MISCELLANEOUS

 

Section 5.1            Authority;
Effect. Each party hereto represents and warrants to and agrees with each other party that the execution and delivery of this Agreement
and the consummation of the transactions contemplated hereby have been duly authorized on behalf of such party and do not violate any
agreement or other instrument applicable to such party or by which its assets are bound. This Agreement does not, and shall not be construed
to, give rise to the creation of a partnership among any of the parties hereto, or to constitute any of such parties members of a joint
venture or other association. The Company and its subsidiaries shall be jointly and severally liable for all obligations of each such
party pursuant to this Agreement.

 

Section 5.2            Notices.
Any notices, requests, demands and other communications required or permitted in this Agreement shall be effective if in writing and
(i) delivered personally, (ii) sent by e-mail, or (iii) sent by overnight courier, in each case, addressed as follows:

 

If to the Company:

 

Diversey Holdings, Ltd.

1300 Altura Road, Suite 125

Fort Mill, South Carolina 29708

Attention: General Counsel

E-mail: mike.chapman@diversey.com

 

     27 

      

    

 

with a copy (which shall not constitute notice)
to:

 

Kirkland & Ellis
LLP

300 North LaSalle

Chicago, Illinois 60654

Attention: Bradley C. Reed,
P.C.

Christopher M. Thomas, P.C.

Alexander M. Schwartz

E-mail: bradley.reed@kirkland.com;

christopher.thomas@kirkland.com;

alexander.schwartz@kirkland.com;

 

If to Bain Capital:

 

c/o Bain Capital Partners, LLC

John Hancock Tower

200 Clarendon Street

Boston, Massachusetts 02116

Attention: Jonathon Penn

E-mail: jpenn@baincapital.com

 

with a copy (which shall not constitute notice)
to:

 

Kirkland & Ellis
LLP

300 North LaSalle

Chicago, Illinois 60654

Attention: Bradley C. Reed, P.C.

Christopher
M. Thomas, P.C.

Alexander M. Schwartz

E-mail: bradley.reed@kirkland.com;

christopher.thomas@kirkland.com;

alexander.schwartz@kirkland.com;

 

Notice to the holder of record of any Registrable
Securities shall be deemed to be notice to the holder of such securities for all purposes hereof.

 

Unless otherwise specified herein, such notices
or other communications shall be deemed effective (i) on the date received, if personally delivered, (ii) on the date sent
if delivered by e-mail on a Business Day, or if not delivered on a Business Day, on the first Business Day thereafter and (iii) two
(2) Business Days after being sent by overnight courier (charges pre-paid). Each of the parties hereto shall be entitled to specify
a different address by giving notice as aforesaid to each of the other parties hereto.

 

Section 5.3            Termination
and Effect of Termination. This Agreement shall terminate upon the later of (i) the date on which no Holder holds any Registrable
Securities, and (ii) the date on which both Bain Capital ceases to have any right to designate any Director under this Agreement
pursuant to the terms of Section 4.1.2; except for the provisions of Sections 3.9 and 3.10, which shall survive any
such termination. No termination under this Agreement shall relieve any Person of liability for breach or Registration Expenses incurred
prior to termination. In the event this Agreement is terminated, each Person entitled to indemnification rights pursuant to Section 3.9
hereof shall retain such indemnification rights with respect to any matter that (i) may be an indemnified liability thereunder
and (ii) occurred prior to such termination.

 

     28 

      

    

 

 

Section 5.4     Permitted
Transferees. The rights of a Holder hereunder may be assigned (but only with all related obligations as set forth below) in connection
with a Transfer of Registrable Securities to a Permitted Transferee of that Holder. Without prejudice to any other or similar conditions
imposed hereunder with respect to any such Transfer, no assignment permitted under the terms of this Section 5.4 will be
effective unless the Permitted Transferee to which the assignment is being made, if not a Holder, has delivered to the Company a written
acknowledgment and agreement in form and substance reasonably satisfactory to the Company that the Permitted Transferee will be bound
by, and will be a party to, this Agreement. A Permitted Transferee to whom rights are transferred pursuant to this Section 5.4
may not again transfer those rights to any other Permitted Transferee, other than as provided in this Section 5.4.

 

Section 5.5     Remedies.
The parties to this Agreement shall have all remedies available at law, in equity or otherwise in the event of any breach or violation
of this Agreement or any default hereunder. The parties acknowledge and agree that in the event of any breach of this Agreement, in addition
to any other remedies that may be available, each of the parties hereto shall be entitled to specific performance of the obligations
of the other parties hereto and, in addition, to such other equitable remedies (including preliminary or temporary relief) as may be
appropriate in the circumstances. No delay of or omission in the exercise of any right, power or remedy accruing to any party as a result
of any breach or default by any other party under this Agreement shall impair any such right, power or remedy, nor shall it be construed
as a waiver of or acquiescence in any such breach or default, or of any similar breach or default occurring later; nor shall any such
delay, omission nor waiver of any single breach or default be deemed a waiver of any other breach or default occurring before or after
that waiver.

 

Section 5.6     Amendments.
This Agreement may be amended, modified, extended or terminated, and the provisions hereof may be waived, only by an agreement in writing
signed by each of the Company and Bain Capital; provided that in the event that such amendment, modification or waiver would materially
and adversely affect a Holder or group of Holders in a manner substantially different than any other Holders, then such amendment or
waiver will require the consent of the Holder or a majority of the group of Holders (determined based on the number of Registrable Securities
held) materially and adversely affected. Each such amendment, modification, extension or termination shall be binding upon each party
hereto. In addition, each party hereto may waive any right hereunder by an instrument in writing signed by such party.

 

Section 5.7     Governing
Law. This Agreement and all claims arising out of or based upon this Agreement or relating to the subject matter hereof shall be
governed by and construed in accordance with the domestic substantive laws of the State of New York without giving effect to any choice
or conflict of laws provision or rule that would cause the application of the domestic substantive laws of any other jurisdiction.

 

    29 

     

    

 

Section 5.8     Consent
to Jurisdiction. Each party to this Agreement, by its execution hereof, (i) hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the State of New York for the purpose of any action, claim, cause of action or suit (in contract,
tort or otherwise), inquiry, proceeding or investigation arising out of or based upon this Agreement or relating to the subject matter
hereof, (ii) hereby waives to the extent not prohibited by applicable law, and agrees not to assert, and agrees not to allow any
of its subsidiaries to assert, by way of motion, as a defense or otherwise, in any such action, any claim that it is not subject personally
to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that any such proceeding
brought in one of the above-named courts is improper, or that this Agreement or the subject matter hereof or thereof may not be enforced
in or by such court and (iii) hereby agrees not to commence or maintain any action, claim, cause of action or suit (in contract,
tort or otherwise), inquiry, proceeding or investigation arising out of or based upon this Agreement or relating to the subject matter
hereof or thereof other than before one of the above-named courts nor to make any motion or take any other action seeking or intending
to cause the transfer or removal of any such action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding
or investigation to any court other than one of the above-named courts whether on the grounds of inconvenient forum or otherwise. Notwithstanding
the foregoing, to the extent that any party hereto is or becomes a party in any litigation in connection with which it may assert indemnification
rights set forth in this Agreement, the court in which such litigation is being heard shall be deemed to be included in clause (i) above.
Notwithstanding the foregoing, any party to this Agreement may commence and maintain an action to enforce a judgment of any of the above-named
courts in any court of competent jurisdiction. Each party hereto hereby consents to service of process in any such proceeding in any
manner permitted by New York law, and agrees that service of process by registered or certified mail, return receipt requested, at its
address specified pursuant to Section 5.2 hereof is reasonably calculated to give actual notice.

 

Section 5.9     WAIVER
OF JURY TRIAL. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH PARTY HERETO HEREBY WAIVES AND COVENANTS
THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE
OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR OTHERWISE), INQUIRY, PROCEEDING OR INVESTIGATION ARISING OUT OF
OR BASED UPON THIS AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE TRANSACTIONS CONTEMPLATED
HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING. EACH PARTY HERETO ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY THE
OTHER PARTIES HERETO THAT THIS SECTION 5.9 CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH THEY ARE RELYING AND WILL RELY IN ENTERING
INTO THIS AGREEMENT. ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 5.9 WITH ANY COURT AS
WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY.

 

Section 5.10     Merger;
Binding Effect, Etc. This Agreement constitutes the entire agreement of the parties with respect to its subject matter, supersedes
all prior or contemporaneous oral or written agreements or discussions with respect to such subject matter, and shall be binding upon
and inure to the benefit of the parties hereto and thereto and their respective heirs, representatives, successors and permitted assigns.
Except as otherwise expressly provided herein, no Holder or other party hereto may assign any of its respective rights or delegate any
of its respective obligations under this Agreement without the prior written consent of the other parties hereto, and any attempted assignment
or delegation in violation of the foregoing shall be null and void.

 

    30 

     

    

 

Section 5.11     Counterparts;
Electronic Signature. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original, but all
of which taken together shall constitute one instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile,
electronic mail or other transmission method as permitted by applicable law, and the parties hereto agree that any counterpart so delivered
shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. A party’s electronic signature
(complying with the New York Electronic Signatures and Records Act (N.Y. State Tech. §§ 301-309), as amended from time
to time, or other applicable law) of this Agreement shall have the same validity and effect as a signature affixed by the party’s
hand.

 

 

Section 5.12     Severability.
In the event that any provision hereof would, under applicable law, be invalid or unenforceable in any respect, such provision shall
be construed by modifying or limiting it so as to be valid and enforceable to the maximum extent compatible with, and possible under,
applicable law. The provisions hereof are severable, and in the event any provision hereof should be held invalid or unenforceable in
any respect, it shall not invalidate, render unenforceable or otherwise affect any other provision hereof.

 

Section 5.13     No
Recourse. Notwithstanding anything that may be expressed or implied in this Agreement, the Company and each Holder covenant, agree
and acknowledge that no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement shall
be had against any current or future director, officer, employee, general or limited partner or member of any Holder or of any Affiliate
or assignee thereof, as such, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any
statute, regulation or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach
to, be imposed on or otherwise be incurred by any current or future officer, agent or employee of any Holder or any current or future
member of any Holder or any current or future director, officer, employee, partner or member of any Holder or of any Affiliate or assignee
thereof, as such, for any obligation of any Holder under this Agreement or any documents or instruments delivered in connection with
this Agreement for any claim based on, in respect of or by reason of such obligations or their creation.

 

[Signature pages follow]

 

    31 

     

    

 

IN WITNESS WHEREOF,
each of the undersigned has duly executed this Agreement as of the date first above written.

 

	 	DIVERSEY HOLDINGS, LTD.
	 	 
	 	By:	/s/ Michael Chapman
	 	Name: 	Michael Chapman
	 	Title:	 General Counsel

 

[Signature pages to Investor Rights Agreement]

 

     

     

    

 

	 	bain capital:
	 	 
	 	Bain Capital Fund XI, L.P.
	 	 
	 	By: Bain Capital Partners XI, L.P.
	 	Its: General Partner
	 	 
	 	By: Bain Capital Investors, LLC
 Its: General Partner

	 	 	 
	 	By:	/s/ Ken Hanau
	 	Name:	Ken Hanau
	 	Title:	Director

 

	 	BCPE Diamond Cayman Holding Limited
	 	 

	 	By:	/s/ Ken Hanau
	 	Name:	Ken Hanau
	 	Title:	Director

	 	 
	 	BCIP Associates IV, LP
	 	 
	 	By: Boylston Coinvestors, LLC
 Its: General Partner

 

	 	By:	/s/ Ken Hanau
	 	Name:	Ken Hanau
	 	Title:	Authorized Signatory

 

[Signature pages to Investor Rights Agreement]

 

     

     

    

 

	 	Bain Capital:
	 	 
	 	BCIP Associates IV-B, LP
	 	 
	 	By: Boylston Coinvestors, LLC
 Its: General Partner

 

	 	By:	/s/ Ken Hanau
	 	Name:	Ken Hanau
	 	Title:	Authorized Signatory

 

	 	BCIP Trust Associates IV, LP
	 	 
	 	By: Boylston Coinvestors, LLC
 Its: General Partner
	 	 

	 	By:	/s/ Ken Hanau
	 	Name:	Ken Hanau
	 	Title:	Authorized Signatory

 

	 	BCIP Trust Associates IV-B, LP
	 	 
	 	By: Boylston Coinvestors, LLC
 Its: General Partner
	 	 

	 	By:	/s/ Ken Hanau
	 	Name:	Ken Hanau
	 	Title:	Authorized Signatory

 

[Signature pages to Investor Rights Agreement]

 

     

     

    

 

	 	INVESTORS:
	 	 
	 	/s/ Philip Wieland
	 	Name: Philip Weiland
	 	 

	 	/s/ Todd Herndon
	 	Name: Todd Herndon
	 	 
	 	/s/ Paul Budsworth
	 	Name: Paul Budsworth
	 	 
	 	/s/ Gaetano Redaelli
	 	Name: Gaetano Redaelli
	 	 
	 	/s/ Somer Gundogdu
	 	Name: Somer Gundogdu
	 	 
	 	/s/ Rudolf Verheul
	 	Name: Rudolf Verheul
	 	 
	 	/s/ Jorge Hileman Rivera
	 	Name: Jorge Hileman Rivera
	 	 
	 	/s/ Himanshu Jain
	 	Name: Himanshu Jain
	 	 
	 	/s/ Suzanne Thompson
	 	Name: Suzanne Thompson

 

[Signature pages to Investor Rights Agreement]

 

     

     

    

 

	 	/s/ Lex Tiedemann
	 	Name: Lex Tiedemann
	 	 
	 	/s/ Michael Del Priore
	 	Name: Michael Del Priore
	 	 
	 	/s/ Michael Chapman
	 	Name: Michael Chapman
	 	 
	 	/s/ Brad Weber
	 	Name: Brad Weber
	 	 
	 	/s/ Joshua Paulson
	 	Name: Joshua Paulson
	 	 
	 	/s/ Sinead Kwant
	 	Name: Sinead Kwant
	 	 
	 	/s/ Frank Theis
	 	Name: Frank Theis
	 	 
	 	/s/ Steven Ma
	 	Name: Steven Ma
	 	 
	 	/s/ Julia Velichiko
	 	Name: Julia Velichiko
	 	 
	 	/s/ Annette Bergknut
	 	Name: Annette Bergknut

 

[Signature pages to Investor Rights Agreement]

 

     

     

    

 

 

	 	BAIN & COMPANY, INC.
	 	 

	 	By:	/s/ Michael Chapman

	 	Name:	Michael Chapman

	 	Title:	Authorized Signatory

 

	 	SQUAM LAKE INVESTORS XI, L.P.
	 	 
	 	By: BGPI, Inc.
	 	Its: General Partner

 

	 	By:	/s/ Michael Chapman

	 	Name:	Michael Chapman
	 	Title:	Authorized Signatory

	 	 
	 	RANDOLPH STREET INVESTMENT

 PARTNERS, L.P. - 2016 DIF
	 	 
	 	By: Randolph Street Investment Management, LLC
	 	Its: General Partner
	 	 

	 	By:	/s/ Michael Chapman

	 	Name:	Michael Chapman
	 	Title:	Authorized Signatory

 

[Signature pages to Investor Rights Agreement]

 

     

     

    

 

	 	ARCADIA CAPITAL
	 	 

	 	By:	/s/ Michael Chapman

	 	Name:	Michael Chapman
	 	Title:	Authorized Signatory
	 	 

	 	COLONIAL RIVERS, LLC

  

	 	By:	/s/ Michael Chapman

	 	Name:	Michael Chapman
	 	Title:	Authorized Signatory

 

[Signature pages to Investor Rights Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]